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ABSTRACT 
 
miRNAs are essential regulators of cell fate and involved in several human diseases, although 
their biogenesis is a well-accepted paradigm (microprocessor, Exp5, Dicer, and Argonaute). New 
evidence revealed different biogenesis for miRNAs distinct to canonical miRNA pathway; this 
new source of miRNAs including mirtrons, Exp1 dependent and Dicer-independent miRNAs, 
furthermore also others ncRNAs like tRNAs and snoRNAs produce fragments that reflects Dicer 
processing and Argonaute incorporation in sRNA profiles, however, functional evaluation and 
mechanisms are still poorly described. Studying C/D snoRNA-derived miRNAs using NGS profiles 
(sRNA-seq and CLIP of ribonucleoproteins) called small RNA fragments derived from C/D snoRNA 
loci poorly recovered from miRNP (Argonaute, Dicer) but strongly associated to snoRNPs 
(Nop56, Nop58, and FBL). However, U3 (C/D snoRNA) suited as a bona fide source of miRNAs 
including defined mRNA targets. To test functionality in-vivo at high resolution, I generated, 
implemented and validated a single cell assay for miRNA posttranscriptional regulation. Using 
this system U3 derived fragments perform as low expressed miRNAs in vivo in the Hek293 model 
and hold mRNA endogenous targets. 
In conclusion, using NGS data and the high-resolution reporter system, this study showed that 
non-canonical U3 C/D snoRNA is a bona fide miRNA source, while intronic C/D snoRNA-derived 
fragments rather might be degradation products.
 1 
 
1 INTRODUCTION 
 
RNA biology paradigms redefined themselves and evolved quickly, bringing together fascinating 
ideas and scenarios where the flexibility and multi-faceted RNA nature surprises us with 
unconceived mechanisms 1.  
However, this increased flexibility and boost of information have created different "schools”2,3 
around particular phenomena, lacking consensus perspectives or paradigms. Bulding 
applications and research based on incomplete or poorly understood mechanisms. For example, 
Gunther Meister’s lab revealed that snoRNAs and tRNAs could generate miRNA-like molecules 
and described their biogenesis path 3-5. But deeper understanding and systematicity around the 
mechanism are inadequate. Since then many studies reported tRNA or snoRNA fragments 
suggesting association with pathological scenearios, assuming Meister's evidence as a paradigm 
and not as proof of principle that requires replication and further validation, as many reviews 
claim 6-11. 
As my central research interest, I want to characterize the function of snoRNA-derived miRNAs. 
So, I will introduce small RNAs current paradigms, including function and biogenesis, examining 
common trafficking factors and functional differences.  I will focus on current miRNA models of 
transcription, transport, and processing. Also, I will discuss recent experimental advances, 
concentrating on the lack of high-resolution sensors.   
Finally, I will outline the canonical function and biogenesis of snoRNAs, including a description of 
new features, evidence for them, and the flaws that require experimental clarification or 
validation. 
SMALL RNAS: PETITE GENOME REGULATORS 
 
Small RNAs are the best-studied non-coding RNAs (ncRNAs) and what we know about their 
genesis, processing, and mechanisms exemplify RNA diversity. Interestingly their trafficking 
principle is not unique and probably governed by the requirements of the cell rather than RNA 
subtype exclusive pathway12.  
Current consensus classifies ncRNAs arbitrarily by size creating two types of ncRNA: long non-
coding RNAs (lncRNA) and small RNAs (sRNAs), while the firsts are larger than 200 nt, the 
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seconds are shorter13.  Besides the different functions, the small RNAs have in common that they 
use base-pairing interactions to modify their target RNAs, for what they associate with RNA 
binding proteins (RNP). 
The small RNAs include snRNA, snoRNA, and miRNA: small nuclear RNAs (snRNAs) aid intron 
removal, small nucleolar RNAs (snoRNAs) guide rRNA chemical modifications and miRNAs 
regulate gene expression by inducing degradation or translational repression of mRNAs.  
1.1.1 SMALL NUCLEAR RNA: CUT AND PASTE TO DIVERSIFY EXPRESSION 
 
Small nuclear RNAs are abundant and non-polyadenylated RNAs located mainly at the 
nucleoplasm; they are the spliceosome core and catalyze intronic removal. Within snRNA there 
are two distinct classes: Sm and Lsm classes, divided accordingly to sequences motif and 
interacting proteins, the Sm snRNA classes include U1, U2, U4, U5, U7, U11, and U12, while U6 is 
a Lsm snRNA.  
Lsm class snRNAs have a monomethyl phosphate cap, a 3' stem-loop, and a uridine stretch that 
serves as the binding site for the Lsm proteins, while the Sm-Class snRNA have a 5'-
trimethylguanosine cap, a 3' stem loop, and the Sm proteins binding motif12. 
snRNA splicing activity requires ribonucleoproteins to organize it with the pre-mRNA, the snRNA-
mRNA interaction resembles the conformation of the RNA-based catalytic center of group II 
introns. The snRNPs flexibility allows a precise regulation that enables interaction with different 
intronic sizes and control of alternative splicing. Reviews from Lührmann and Shi 14,15 describe 
mechanistic details on the structure and chemistry of catalytic steps during splicing.  
RNA polymerase II transcribes all Sm snRNAs and couples their 3' processing. After transcription 
three proteins (Cap binding protein, adaptor PHAX and Exportin 1) bring snRNAs to the 
cytoplasm; a process that is dependent on GTP and PHAX phosphorylation state. In the 
cytoplasm, the SMN complex assembles the Sm core (a ring of 7 sm proteins), while TSG1 sets 
the snRNA three methyl cap. Finally, Snurportin1 (SPN) and importin B return the snRNAs to the 
nucleus, where in the Cajal bodies snRNAs get further modified and end in the nucleoplasm to 
be part of the spliceosome (Figure 1). 
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Reproduced with permission from Matera et al.12 
Figure 1. Biogenesis of small nuclear RNPs 
Cartoon depicts the transcription, trafficking and modification of SM snRNA.  
U6 has a different processing; it remains in the nucleus, is not trimethylated and is transcribed 
by polymerase III. Furthermore, in contrast to other Sm snRNAs, U7 has a distinct SM motif12.  
1.1.2 MICRORNAS: TINY REGULATORS OF GENE EXPRESSION 
 
miRNAs are by far one of the greatest revolutions in RNA and cell biology; it is probably the 
"millennial" discovery and quickly scaled as a new paradigm that we take for granted and even 
included in high school curricula, meaning that miRNAs override the specialized knowledge and 
enter human kind collective consciousness.  
microRNAs regulate gene expression by  binding to mRNAs by sequences complementarity. 
Initially, described as an odd discovery in C.elegans16,17, and considered relevant until 2001 when 
several groups reported numerous 21 to 25 nt RNAs that were unambiguously conserved in 
evolution and relevant for development; that year the term miRNA was born 18-20.  
miRNA genes yield bigger precursors than the final mature counterparts; Polymerase II 
transcribes the pri-miRNA as a polyadenylated and  7mG capped transcript. Then the 
microprocessor, which includes DROSHA and DGCR8, processes it and produces a shorter 
version (~70 nt) with a stem-loop structure (pre-miRNA), later it is transported to the cytoplasm 
by Exportin 5. In the cytoplasm, the endonuclease DICER, which interacts with the TRBP protein, 
cuts the stem loop and generates a RNA duplex. Afterward, the duplex is released, and the heat 
shock cognate (HSC70) and the heat shock protein 90 (HSP90) hydrolyse ATP to load the RNA 
duplex in the Argonaute proteins, which select the guide strand by 5' stability of the duplex8.  
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miRNAs repress gene expression by four different ways: they degrade the transcript, inhibit 
translation elongation, induce early termination of translation or avoid its initiation. miRNAs 
cause degradation by removing the m7G cap and reducing the length of the poly A tail. As well, 
they sequester transcripts in P-bodies inhibiting translation21. 
1.1.2.1 microRNAs Biogenesis 
 
The cell generates the vast majority of miRNAs through the pathway described above. However 
several studies point to alternative routes for miRNAs biogenesis, and the paths can be grouped 
into 6 clusters according to their genomic location, processing, and trafficking proteins. I 
organized the groups according to the similarities to the canonical miRNAs; meaning that group 
II is almost identical to the textbook miRNA biogenesis and VI is essentially a different path 
(Figure 2).  
 
 
Reproduced and modified with permission from Ha and Kim 8 
Figure 2. Biogenesis of microRNAs 
miRNA groups defined by biogenesis: I. canonical miRNAs, II. let-7 that requires a extra mono 
uridylination, III. Mirtrons that do not require the microprocessor, IV. Dicer independent but 
require Argonaute 2 catalytic activity, V. m7-Cap at the 5’ miRNA that do not requires DGCR8*, 
and are XPO1 dependent, VI. Other source of miRNAs.  
*Group V XPO1 dependent could have m7-Cap or TMG-Cap. 
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Group I corresponds to the canonical pathway (m7G-cap and poly A, microprocessor-Exp5-Dicer-
Ago) 8. The second group is similar to canonical miRNAs, but it holds an extra step; usually, Dicer 
substrates require a 3' overhang of 2 nucleotides and the group II let-7 family only possesses one 
nucleotide, so mono-uridyl transferases (TUT) add the missing nucleotide, allowing processingby 
Dicer 22. The third group comprises the Mirtrons (intronic miRNAs) that require the spliceosome, 
the debranching enzyme activity and trimming by nucleases before Exp5 shipps them out the 
nucleus to continue with miRISC formation23,24. The group IV is Dicer-independent and requires 
the catalytic activity of Ago2, since its stem is too short to be processed by Dicer. Ago2 cuts the 
miRNAs while the nuclease PARN trims it, producing a RISC complex with a miRNA of 23 nt25,26.  
Finally, group V miRNAs are transcribed similarly to snRNAs. Hence, they have a 7mG cap and 
probably are subjected to 3' terminal processing. As snRNA they are transported to the 
cytoplasm by PHAX and XPO1; because the cap, just the 3' branch of the hairpin is effectively 
loaded in Ago 27,28. Furthermore, a subset of these miRNAs is expressed in starvation conditions, 
because Exportin V expression is decreased while the Exportin I transports this subset of miRNAs 
29.  Summarizing the group V, which mainly described by Joan Steitz lab excellent studies, is a 
collection of miRNAs that require XPO1 transport and have either 7mG-cap or TMG-cap 
depending on the metabolic cell status 27,29. 
The group VI includes miRNA derived from another ncRNA like snoRNAs (See below) or tRNAs. 
Their function is still debatable due to their low expression, and probably they are the result of 
leaky processing. For example, tRNAs interact with La proteins avoiding tRNAs to join the miRNA 
biogenesis pathway4,5. 
1.1.2.2 Experimental strategies for microRNA functionality 
 
For the evaluation of miRNAs several biochemical and computational techniques have been 
developed in the field. These allow us to unravel the details of new mechanims and associations 
that are applicable to clinical scenarios. For the evaluation of miRNAs several biochemical and 
computational techniques have been developed in the field. These allow us to unravel the 
details of new mechanims and associations that are applicable to clinical scenarios. I will 
concentrate on high-throughput procedures, including profiling methods, in vivo target 
validations and single-molecule imaging. Moreover, I will further describe the gap between 
biochemical and the functional resolutions: while the biochemical techniques include 
quantitative high-throughput data, functionality in vivo is still qualitative 21.   
 6 
To have working definitions, I refer here as functionality to any experimental approach that 
evaluates the reduction of targets, and its phenotypic consequences, i.e., luciferase-based 
assays that quantify sensor changes in response to miRNAs in vivo. I describe here as in vivo to 
any test performed in a living system including cell culture; and I call biochemical approaches to 
miRNAs or target molecules quantification using amplification, cDNA synthesis, 
immunoprecipitation and others. 
 Steinkraus21 describes in detail the experimental advances in miRNA discovery; however, I will 
summarize this review and include newly developed techniques that are not cited or poorly 
explained. 
1.1.2.2.1 miRNA profiling and capture-based techniques 
 
Deep sequencing and mass spectrometry have increased the possibilities to evaluate miRNAs 
and gene expression. However, The first and probably most used inquiry for miRNAs is primarily 
miRNA profiling. Briefly, it counts the number of miRNA molecules and runs statistical analyses 
to get differential expression either of miRNAs or mRNA, connecting the outputs (miRNA-mRNA 
targets) by computational dissection. Together, these profiles generate hypothesis that need 
further experimental evaluation.  
Using miRNA exogenous expression or inhibition, scientists can evaluate and quantify miRNA 
targets. Depending on the mechanism they are eager to study, miRNA can either induce mRNA 
degradation or translation inhibition (see 1.1.2). Consequently, mRNA analysis on cDNA level 
(qPCR or next generation sequencing) evaluates RNAs degradation,  mass spectrometry defines 
the affected coding targets, and ribosome profiling determines which miRNAs targets are 
translationally repressed. 
Both strategies collect the total miRNA content, including then Argonaute bound molecules, 
miRNA in biogenesis, differentially localized or bound to free mRNA. So biochemist developed 
bait-based techniques in which miRNAs are linked to the effector molecule, narrowing down to 
the functional miRNA pool. 
Primary profiling capture-based recoveries rely on cDNA synthesis and analysis (qPCR, 
microarrays or NGS), and differ on protein purification and RNA stability. Therefore, they are 
dependent on several factors: if the RNA can be crosslinked to Argonaute or not, or if it is 
performed via RNA immunoprecipitation (RIP) or crosslink-immunoprecipitation (CLIP). 
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CLIP approaches differ on their cross-linking mechanism, either they use photoactivatable 
ribonucleosides or the natural RNA trend to react with specific amino acids using 254 nm light. 
Moreover, including a ligation RNA-RNA, it is possible to sequence miRNA-mRNA targets, calling 
those hybrids chimeric reads. 30-32. 
Hybrids can be found in several data sets, and some chimeric calls do not require an extra 
ligation step32. Recently, Amy Pasquinelli's lab developed a PCR amplification of chimeras, 
allowing cheaper and focused evaluation of in vivo derived chimeras (ChimP)33. 
1.1.2.2.2 Systems Biology and in-vitro single molecules studies 
 
Recently FRET-based in vitro assays calculated kinetic parameters for AGO-miRNA binding and 
RISC formation, increasing the understanding of miRNA target recognition and the structural 
basis that allows better insights into the miRNA targeting mechanism from mRNA-miRNA 
hybrids and structural studies34,35. Since laboratory scientists use different techniques and the 
classic biochemistry approaches have difficulties to integrate data. Computational scientists 
develop algorithm to understand the complicated miRNA networks  36,37.  
To solve this issue, many system biologists use high-throughput sequencing data, phenotyping 
studies and in vitro kinetics to build a better look at the whole miRNA functional network. 
Thanks to system biology we understand miRNAs fine-tuning behavior and their switch-like 
control of gene regulation 38-40.  
Modeling miRNA networks allows to understand in a broad sense the miRNA induced regulation; 
these models generate confident predictions. Sadly, just few scientists use the models and apply 
them to new experimental questions, making a prospective analysis of their predictions. 
Rephrasing, we use data to create models, confirm the models retrospectively and often without 
testing their predictions experimentally.  
Therefore, I decided to use the mathematical models for miRNAs to test empirically the group VI 
miRNAs derived from C/D snoRNAs (see section 0). 
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1.1.2.2.3 Functional sensors of miRNA activity: High-resolution sequencing in a weak 
functional read outs world 
 
The increasing complexity and detail of information yielded by miRNA profiling and Argonaute 
FRET did not result in a boost of better in vivo reporters.  
Commonly, scientists involved in exhaustive biochemical characterizations (Bait profiling) tested 
functional miRNA-mRNA interaction using luciferase reporter assays 5,21,30. These experiments 
require two proteins, the response element for miRNAs and a reference protein, to create 
quantitative results (ratios) for miRNA regulation and target validation for mammalian cells. But 
luciferase outputs dismissed the intricate functional network behind miRNAs.  
miRNAs with comparable cellular concentration (as detected in miRNA profiling) show a broad 
range of functional outputs. For instance, high-throughput assays for miRNA activity  (based on 
lentiviral libraries of miRNA sensors) showed that only highly abundant miRNAs repressed mRNA 
target and reported that around the 60% of miRNAs displayed no discernable activity 41. 
Moreover, some highly expressed miRNAs have only weak regulatory action. Consequently, 
many studies on miRNAs inhibition suggested that particular miRNA expression thresholds are 
required to obtain a detectable repression 42,43.  
I consider that high-throughput functional studies have low resolution similarly to luciferase 
assays because such libraries require cell selection (antibiotic) and described the whole 
population. Also, their inability to discern down regulation -for up to 60% of the evaluated 
miRNAs- contradicts the fact that inhibition of mildly expressed miRNAs displayed discernible 
phenotypes. (See regulation of non-canonical targets of miR92a in CLASH 30) 
For that reason, I generated a single plasmid reporter assay and validated it for miRNAs. To 
increase resolution I used fluorescent proteins instead of luciferase and quantified them at 
single cell level using flow cytometry. To analyze the enormous amount of data points from 
individual cell measurements: I adapted a titration model of miRNAs regulation44, tested its 
predictions prospectively for canonical miRNAs and applied it for non-canonical miRNAs or 
Group VI. (See scope of the thesis section 0). 
1.1.3 SMALL NUCLEOLAR RNA: MODIFYING TO DIVERSIFY RNAS  
 
Small nucleolar RNAs (snoRNA) are an abundant set of noncoding RNA that mainly guide 
chemical modification of ribosomal RNA. The two classes of snoRNAs are H/ACA and C/D 
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snoRNAs: each type has a particular sequence, structure, associated RNPs, and guide pseudo-
uridylylation (H/ACA) and 2' O methylation (C/D )of rRNA. Some snoRNAs chaperone rRNA and 
participate in the external and internal transcribed spacers (ETS and ITS) cleavage of the pre-
rRNA 7,12.  
The H/ACA box snoRNAs structure contains two hairpins separated by a hinge holding the H 
motif (ANANNA, N=any base),  with the ACA motif at their 3' end. The stem loop's bottom, 
embedded in the hairpins, interacts with the rRNA and sets the nucleoside to isomerize. The 
H/ACA snoRNPs are dyskerin (the pseudouridine synthase), GAR1 (nucleolar protein family A, 
member 1, NOLA1), NHP2 (NOLA2) and NOP10 (NOLA3).  The C/D box snoRNAs hold the 
conserved boxes C (RUGAUGA, R=purine) and D (CUGA) located at their 5' and 3' end, 
respectively; the two motifs interaction forms a kink-turn structure with a terminal stem (~ 4 to 
5 bp). Frequently, C/D snoRNAs contain incomplete C and D box copies, denominated C' and D' 
and located internally6,9,45 (Figure 3). 
 
Reproduced with permission from Matera and Terns 12 
 Figure 3. Structure of small nucleolar RNAs 
Figure depicts the anatomy of (A) C/D snoRNAs (B) H/ACA snoRNAs and U3 C/D snoRNA. It 
shows in yellow rectangles the sequence motifs, blue lines represent the snoRNAs while the red 
lines depict target RNA. 
Looking in direction 5' to 3' the canonical snoRNA motif and guide sequences (gs) order are C - gs 
- D'- C'-gs-D. The 2'O-ribose methylation of target RNAs occurs precisely five nucleotides from 
the D or D' box.   The C/D snoRNPs are Fibrillarin (FBL, the methyltransferase), NOP56 (or 
NOL5A, nucleolar protein 5A), NOP5/NOP58 and 15.5K 6,9,45.  
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1.1.3.1 snoRNA biogenesis and control 
 
snoRNAs evolved differently, generating several gene organization and transcription strategies. 
Overall snoRNAs could be intronic or not, polycistronic or monocistronic, and pol-II or pol-III 
dependent (For details see 46). In humans, snoRNAs are primarily intronic (one snoRNA per 
intron), included mainly in 5' TOP transcripts that codify for ribosomal proteins, but can also be 
found in noncoding transcripts, i.e. Gas5 or SHG loci.  
Pol II transcribes H/ACA snoRNAs, and the snoRNPs assembly occurs co-transcriptionally or early 
after transcription. Their hosting introns are longer, and the splicing and the snoRNP are 
separate events. After debranching and trimming the snoRNPs end up in the nucleolus 45,47 
(Figure 4). 
 
Adapted and modify from Figure 2 in Kiss 45.  
Figure 4. Biogenesis of intronic small nucleolar RNAs 
Figure depicts snoRNA biogenesis and associated proteins; RNA is depicted in red and snoRNAs 
are the orange squares, the arrow describes the distance between snRrNA gene and the 
branching points (Black dot). 
In contrast to H/ACA snoRNA, C/D snoRNAs require the splicing machinery for their correct 
processing. The majority of snoRNAs have a distance of approximately 50 nt between the 
snoRNA gene and their hosting intron's branching point. After the first catalytic step of splicing 
occurs and the complex C1 is formed (Lariat and 3' exon) 48,49, the protein IBP160 couples the 
protein 15.5K with the intronic snoRNAs allowing a correct folding. Then the second catalytic 
step yields two components: the hosting snoRNA lariat and the exon-exon spliced mRNA. 50.  
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Afterward, the debranching enzyme opens the lariat, and the exosome endonuclease DIS3 trims 
the snoRNAs, which requires the NEXT complex and probably occurs in the nucleoplasm. Then 
snoRNAs are transported into the nucleolus51. In yeast, the debranching step determines the 
snoRNA mature formation and function, but no evidence has been reported in the mammalian 
system 52,53. 
The mature snoRNA steady state levels are controlled in yeast by the TRAMP complex and the 
nuclear exosome54, while in humans, EXOC10 (the nucleolar exosomal catalytic subunit) 
regulates the mature snoRNA levels 51. hMTR4 is the primary adaptor for the TRAMP and NEXT 
complex of the human nuclear RNA exosome55,56, in yeast mtr4 is the adaptor that controls 
mature snoRNA 54. However the human TRAMP show, in contrast to yeast, differential 
association with exosomal factors in a subnuclear fashion57,58, suggesting a different 
evolutionary path.   
It seems that the NEXT complex (hMTR4- ZCCHC8 and RBM7) adapts the processing of immature 
snoRNAs after debranching, while the TRAMP homologs (hMTR4, ZCCHC7, and hTRF4-2) 
regulate the mature form. Furthermore, DGCR8, part of the pri-miRNAs processing machinery, 
works as an adaptor of the exosome for mature snoRNAs in the nucleolus 59. It will be interesting 
to see how the two exosomal adaptors hMTR4 and DGCR8 control snoRNAs mature steady state 
levels (See results 2.1.31 hMTR Knock-down). 
1.1.3.2 U3 typical non-intronic C/D snoRNAs 
 
U3, U8, and U13 are not-intronic snoRNA transcribed by Polymerase II, and their biogenesis uses 
various trans acting factors. In contrast to other snoRNAs, these participate in rRNA processing 
rather than its methylation, and U3 processing and biogenesis are relatively well studied60-62. 
U3 has two unique domain: the 5', that contains the conserved sequences: CAG, A' and A boxes, 
and the 5' and 3' hinges, the latter resembles other C/D snoRNAs carrying a C', C and D boxes 
(Figure 3). In contrast to other snoRNAs, U3 has a conserved motif B interacting with the C box 
and is necessary for the interaction with its unique protein U3-55K. The A and A' motifs base-
pair with the 18S rRNA and the hinges interact with the pre-rRNA 5' ETS, which is necessary for 
the accurate pre-rRNA processing. The 3' domain interacts with the snoRNPs (Nop58, Nop56, 
FBL, 15.5K, and U3-55K), and it keeps the U3 located in the nucleolus. Mutations of these motifs 
result in U3 mislocation 60-62.  
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Interestingly, regulation of U3-55K seems to control ribosome biogenesis; cell differentiation 
reduces U3-55k expression and snoRNA U3 levels, reducing pre-rRNA processing63. Recently, the 
Voit group showed that stalled ribosome biogenesis during stress induces U3-55K 
hyperacetylation, which lessens its interaction with U3, reducing pre-rRNA processing 64.   
After transcription, U3 interacts with CBC and PHAX, and like snoRNAs it has a trimethylated cap. 
But it appears that a cytoplasmic phase is not required because TGS1 (see snRNAs) holds two 
isoforms differentiated by an NLS 65,66. For U3 the TGS1 nuclear isoform modifies the cap, while 
Exportin 1 transports it to the nucleolus 60,67. Intriguingly, U3 can be located in the cytoplasm in 
starving cells, at the end of the cell cycle, and sometimes during biogenesis 61,68,69. However, 
reviews skipped this conflicting evidence and settled that U3 has no cytoplasmic phase (For 
details I recommend the discussion from Watkins in U8 and U3 biogenesis publication 69) (Figure 
5). 
 
Figure 5. Biogenesis of U3 small nucleolar RNA 
U3 is transcribed by RNA polymerase II and undergoes through a set of multi-dynamic protein-
RNA interactions in the nucleoplasm. 
1.1.3.3 snoRNA sources of miRNA like molecules 
 
De novo sequencing of ncRNAs displayed an accumulation of 19-40 nt RNA 70, including 
segments from snoRNAs and tRNAs, and several clinical studies show differential processing of 
those derived miRNAs. However, an agreement for functionality is unclear and contradictory. 
Below I will describe the experimental evidence for each proposed feature and the conceptual 
holes that require empirical testing and are the center of this dissertation.  
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In 2008, Miester’s lab Ago RIP-seq experiments showed that the H/ACA snoRNA 45 produces 
miRNAs in a Drosha-independent manner but require Dicer activity 4. Then, Michelle Scott 
described similar processing for C/D and H/ACA box and how annotated miRNAs show snoRNA 
motifs, always using computational analysis, next generation sequencing and northern blots, 
without any functional read-outs 9,71-73. 
In 2011, Brameier et al., described the processing of C/D snoRNAs resembling guide and 
passenger strand distribution of miRNAs. They included several human cell lines and used 
luciferase assays that showed modulation upon insertion of miRNA-like complementarity74, 
However, no deeper statistical analyses or confirmation tests were applied (See Figure 3 from74). 
For that reason, we considered studying those C/D snoRNA-derived miRNA using a systematic 
approach (For the definition of systematicity I recommend Paul Hoyningen-Huene’s paper 75). 
 Many reviews described as interesting that snoRNAs could generate miRNA-like molecules, 
defining as priority the need of experimental validation and advice to keep caution working with 
the group VI miRNAs (see 1.1.2.1) especially, due to their low conservation and low expression 6-
11. 
1.1.3.4 snoRNA novel functions 
 
Several studies proposed that snoRNA-derived miRNA molecules can control alternative splicing. 
Still, it is not clear whether the mature or tiny forms perform this activity 10,11,76. Alternatively, 
other sources proposed that snoRNA-derived miRNAs work together with Piwi proteins and 
control transcription epigenetically 77,78. 
Finally, sequencing of RNA-RNA interactions show that snoRNAs control mRNA steady state 
demonstrating that snoRNA can control coding genes expression 79. Scott and colleagues noted 
similar effect for exogenous snoRNAs expression vectors, where replacing sequences between 
the C and D boxes reduced the expression of complementary mRNA 80. 
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AIMS OF THE THESIS 
 
To rule out that C/D snoRNA-derived miRNAs show functional output as canonical miRNAs, I 
reasoned that a deductive approach, where I look for disproving rather than confirming a 
hypothesis, might generate better evidence.  
As introduced before, the current paradigm for canonical miRNAs predicts several structural, 
biochemical and functional behaviors. I decided to use these predictions for miRNAs as 
references and controls to show whether C/D snoRNA-derived miRNAs can be ruled out as 
canonical miRNAs.  
To characterize structurally and biochemically C/D snoRNA-derived miRNAs, the current 
paradigm predicts that they should have a size of 19 to 22, they should show a consistent 
processing pattern - a defined start and end on their genomic locus, and they should interact 
with Argonaute proteins, as well as Dicer and the microprocessor substrates.  
 From the functional perspective, they should downregulate any mRNA that contains its target 
sequence, have endogenous regulated genes, and functional relation between them. For 
instance, a neuron-expressed miRNA has targets that inhibit glial phenotypes and favors neuron-
related gene expression.  
Experimental biochemical and bioinformatic advances allow in-depth miRNA characterization 
regarding expression and structure, but functional assays still have low resolution, are poorly 
developed and do not allow in vivo miRNA activity quantification.   
To tackle these two issues, C/D snoRNA-derived miRNA, and low in vivo resolution, I used high-
throughput data, mainly NGS from small RNA, RIP and CLIP datasets, to evaluate structurally and 
biochemically miRNAs and applied it to snoRNAs. Second, I generated, tested and validated a 
high-resolution tool for miRNA activity quantification in vivo, and used it for C/D snoRNA-derived 
miRNAs. Finally, I used CLASH-acquired data to sort out endogenous targets of putative snoRNA-
derived miRNA. 
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2 MATERIALS & METHODS 
 
All molecular, microbiological and cell biology methods were performed, if not otherwise stated, 
as described in Current Protocols in Molecular Biology 81. 
 MOLECULAR BIOLOGY 
2.1.1 MIRNA DUAL FLUORESCENT REPORTER GENERATION 
 
Plasmids were constructed using the PsiCheck2 (Promega, Wisconsin, USA) dual luciferase 
reporter backbone: promoters, XhoI and NotI sites were kept, and fluorescent proteins (GFP, 
RFP or CFP) replaced the luciferase genes. Small RNA sequences were derived from miRBase 
(www.mirbase.org) and Oligonucleotides (Sigma-Aldrich, Munich Germany) were designed with 
NotI and XhoI overhangs annealed and ligated into fluorescence plasmid (Supplementary Table 
4), Table 1 summarized the step of the produced the plasmids.  
 
Table 1. Generation of plasmids for Analytical Flow cytometry.  
Annealing reactions were performed in 10 uL final volume including  1 uL of each strand 
(100uM), 1 uL T4 ligase buffer (New England Biolabs, MA, USA) and 0.5 ul T4 polynucleotide 
miRNA sensing plasmid Cloning Strategy  
UTA-1 
 
1. GFP from pAC-GFP-N + psiCHECK-2 
backbone (ApaI-XbaI). 2.  Residual hluc+ 
codon removal by PCR. 3. CFP from 
pcDNA-CFP replacing hRluc (NheI+AsiSI) 
UTA-2 
 
1. PCR YFP extraction pLenti-CaMKIIa-
eArchT 3.0-EYFP PCR (Addgene Plasmid 
#35513) + UTA1.0 (ApaI and XbaI).  
UTA-3 
 
1. RFP pLemiR UTA1.0 (NheI+AsiSI)  
Three different constructs were generated using the psiCHECK-2 backbone and replacing the 
luciferase with fluorescent proteins. 
Tk$ SV40$GFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$YFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$GFP$ RFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$GFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$YFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$GFP$ RFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$GFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$YFP$ CFP$
XhoI$ NotI$
miRNATarget$site$
Tk$ SV40$GFP$ RFP$
XhoI$ NotI$
miRNATarget$site$
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kinase (New England Biolabs, MA, USA); then incubated at 37ºC for 1 h and cooled down from 
95 to 25ºC  at  5ºC/min. The aligned oligonucleotides were ligated to an empty fluorescent 
vector digested with XhoI and SacI (New England Biolabs, MA, USA) for 2 h or overnight at 16 ºC 
then transform into E. coli Top10.  Used oligos are listed in Supplementary Table 4. 
Plasmids are public available In Addgene https://www.addgene.org/browse/article/22044/  
2.1.2 GAS5 CONSTRUCT GENERATION 
 
Hek293 cells genomic DNA was isolated using DNeasy Blood & Tissue Kits (Qiagen, Germany) 
and used as a template for GAS5 PCR amplification using Phusion polymerase (New England 
Biolabs, MA, USA), PCR reactions were performed using 3 % DMSO and two steps PCR. PCR 
products were A tailed using Taq polymerase and 2 mM ATP for 25 min at 72 ºC, and inserted 
into pGEM®-T Easy and pTARGET™(Promega, Wisconsin, USA) following the manufacturer's 
instructions; however, the ligated plasmid were transformed in Top10 instead of JM109. To 
generate pAcGAS5-GFP construct, pAcGFP1-N1 (Takara Bio USA, CA, USA) and pGEM-Gas5 were 
digested with Not I, ligated with T4 ligase  (New England Biolabs, MA, USA) and transformed into 
Top10 E.coli strains. For primers check Table 2. 
2.1.3 BACTERIAL TRANSFORMATION AND COMPETENT CELLS GENERATION AND PLASMID ISOLATION 
 
Competent E.coli Top10 or Stbl3 were prepared using the Mix & Go E. coli transformation buffer 
set from Zymo (Zymo Research Corp. CA, USA), and transformations were performed according 
to manufacturer's instruction. Bacteria cultures were kept at 37 °C on LB-plates or in LB-media. 
Plasmids were isolated using miniprep isolation custom protocol while for transfections plasmids 
were purified using the QIAquick Plasmid Midi Kit (Qiagen, Germany). Using the following 
Antibiotic concentrations: Ampicillin, 100 µg/mL (H2O) (Carl Roth, Germany) and Kanamycin 50 
µg/mL (H2O) (Applichem, Germany).      
2.1.4 POLYMERASE CHAIN REACTION AND RESTRICTION ENDONUCLEASE REACTIONS 
 
Amplification of specific DNA fragments was achieved by polymerase chain reaction using Taq 
(BiothermTM, Germany) or Phusion polymerase (New England Biolabs, MA, USA). According to 
manufacturer's instructions. Results were analyzed by DNA electrophoresis in 1% - 2 %  Agarose 
(w/v), standard electrophoresis was done at 120 V for 45 min in 1X TAE  buffer. For purification 
1/4 of the PCR reaction was analysed by gel electrophoresis and the remaining 3/4 purified using 
QIAquick PCR purification kit.  Used Primers are listed in Table 2 
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Table 2. Standard PCR Primers 
Primer Name Sequences 5’-3’ 
Gas1-Exon-1 FWD agtcgactcctgtgaggtatg 
Gas5-Exon-6 FWD aacttgcctggaccagctta 
Gas5-Exon-11 FWD gcatgcagcttactgcttgaa 
Gas5 Genom FWD cacactccagatggattgcaa 
Gas5  Genom RV cccaggcaccatactgtct 
GFP FWD ctgatcgagctgaatggcga 
GFP REV catcagcgatcttggtggtt 
ECFP-FWD ctaccccgaccacatgaagc 
ECFP-RV tattttattgcggccagcgg 
Luc Out FWD ctaagaacattaagaaggg 
Luc Out RV ggctttaccaacagtacc 
YFP FWD gggcccatggtgagcaagggcgaggag 
YFP RV tctagatcacttgtacagctcgtccatgc 
lncGas5 FWD gagctctttcgaggtaggagtcgac 
lncGas5  RV ccgcggttggattgcaaaaatttatta 
 
Restriction endonuclease reactions were performed according to NEB instructions, Briefly,  
restrictions were performed for 2 h at 37 °C 2. PCR products or desired endonuclease fragments 
were separated by agarose gel electrophoresis and the desired product was purified using the 
QIAquick Gel extraction Kit (Qiagen, Germany) according to manufacturer's directions. DNA 
concentration was measured using Synergy 2 System (Biotek, Winooski, USA) or NanoDropTM 
2000 (Thermo Fisher Scientific, CA, USA) 
PCR products were separated by agarose gel electrophoreses as described in 2.1.4 Size 
separated products were analyzed under UV light and desired product was cut. Excised DNA was 
purified by QIAquick gel extraction kit (Qiagen, Germany). After purification DNA was analyzed 
by Synergy 2 System (Biotek, VT, USA) and 1200 ng of plasmid DNA was diluted in 15 μL nuclease 
free water and send for Sanger sequencing in SEQLAB Sequence Laboratories GmbH, Göttingen, 
Germany or Macrogen, Inc. Seoul, South Korea.    
2.1.5 RNA ISOLATION, SIZE AND INTEGRITY EVALUATION 
 
Total RNA was isolated using Phenol/Chloroform extraction according to producer’s instructions 
(Trizol, Thermo Fisher Scientific, CA, USA). RNA was measured by Synergy system (BioTek, VT, 
USA) or NanoDropTM 2000 (Thermo Fisher Scientific, CA, USA). RNA amount, size distribution 
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and integrity number (RIN) were analysed on a BioAnalyzer System (Agilent, CA, USA) via RNA 
6000 Pico Kit (Agilent, CA, USA). 
2.1.6 CDNA SYNTHESIS AND QUANTITATIVE PCR ANALYSIS 
 
Total RNA (1000 ng) was reverse transcribed using Sensifast cDNA Synthesis Kit (Bioline, London, 
UK) and diluted (1:5 or 1:10). After reverse transcription 25 ng of cDNA were used for 
quantitative analysis on ABI StepOnePlus system (Applied Biosystems, CA, USA). Relative 
expression was calculated via ΔΔCT-method using GAPDH as housekeeping gene; primers used 
for quantification are listed in Table 3. 
Table 3 qPCR Primers 
Primer Name Sequences 5’-3’ Primer Name Sequences 5’-3’ 
Gas-5-FW agctggaagttgaaatgg 40-9 RV ttgacaccgcctaatcttat 
Gas-5-RV-1 caagccgactctccatacc 40-13 RV catttttgaaggaacggtag 
Snord75 FWD cctgtgatgctttaagag 40-14 RV accacctagtactccagcaa 
Snord 75 RV cctcagaatagaatttcag 40-16RV ctggtcataccctggattta 
40-9 FWD ggcatctggactagaatgaa 40-18RV gcaaagttggagacaagaac 
40-13 FWD ggaaatagtggagaaaagca 40-31RV atgttagtgacacctgcaca 
40-14 FWD taacacacttttccccagac 40-38RV cattctggatgcatgtgtag 
40-16 FWD atccatcatctcaccacatt 40-52RV ggtcgtttgagtggactaac 
40-18 FWD tttacctccctctctgttca hMTR4 FWD tccactgagcagcttatccac 
40-31 FWD tgcacaatttcacacctaga hMTR4 RV aaagtagtcgagtcgcgcag 
40-38 FWD ctactgatcacaccctcctc 40-2b FWD gggagtctaaggaaaaggag 
40-52 FWD agttccaagaaaccacacac 40-2b RV cagtgaaaggagagcgtatc 
GAPDH FWD gtcagccgcatcttcttttg 40-33FWD ctggcctagctaaagtctca 
GAPDH RV gcgcccaatacgaccaaatc 40-33 RV tctgctcctagctctcagtc 
 
2.1.7 NGS LIBRARY PREPARATION 
 
Total Isolated RNA was analysed for quality and quantity using BioAnalyzer System (BioAnalyzer 
RNA Pico Kit, Agilent, CA, USA).  Total RNA (2 µg) was purified with the magnetic bead clean-up 
module (Life Technologies, CA, USA) for small RNAs.  Small RNA was ligated with sequencing 
adapters, reverse transcripted and purified (Ion Total RNA-Seq Kit v2, Life Technologies, CA, 
USA). Finally, barcodes were added, and library size and amount were detected via BioAnalyzer 
HS Chip (Agilent, Santa Clara, USA). 
NEXT GENERATION SEQUENCING  
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Libraries were diluted (18pM) and clonal amplified by emulsion PCR on Ion-Torrent OneTouch 
System using the on PGM Template OT2 200 Kit following producer protocol (Life Technologies, 
CA, USA). Amplified libraries were purified using on OneTouch ES System, and loaded into Ion-
Torrent 316 Chip and sequenced via Ion-Torrent PGM System.  
CELL BIOLOGY 
2.1.8 CELL CULTURE  
 
All cell lines were maintained according to ATCC instructions in humidified environment at 37°C 
and 5% CO2. HeLa cells were cultured in RPMI (Roswell Park Memorial Institute) 1640 
supplemented with 10% FCS, whereas DMEM (Dulbecco´s modified Eagle´s Medium) with 15% 
FCS was used for Hek293 cells. 
2.1.9 DNA AND SIRNA TRANSFECTION. 
 
Hek293 cells (100,000 cells/well in 24-well) were transfected using Lipofectamine 2000 
(Thermofisher, MA, USA). Typical transfection was performed with  1 μg plasmidic DNA per well, 
2 μl transfection reagent per 1 μg of  DNA in 100 μl OptiMEM incubated for 20 min; then the 
mixture was added to the cells and incubated for 72h at 37°C and 5% CO2. For co-transfection 
experiments plasmid and siRNA (GL2 or LMNA) (Dharmacon, CO, USA) were transfected into 
Hek293 cells (100,000 cells/well in 24 well plate) with Lipofectamine 2000, for out-competing 
experiments, 20 nM siRNA were added to 1 μg plasmidic DNA with 2 μl Lipofectamine.  
 
siRNA single transfections were performed using 200 nM siRNA and 1 μl lipofectamine, 
incubated for 72 h and RNA was isolated; for double siRNA transfection cells were transfected 
again after 48 h and incubated for two more days previously to RNA isolation. 
Table 4 siRNA used in this work. 
siRNA  Catalog Dharmacon 
GL-2 D-001100-01-20 
LMNA L-004978-00-000 
hMTR4 J-031902-09-0002 
 
2.1.10 LUCIFERASE REPORTER ASSAYS 
 
Hek293 cells were transfected as described in 2.1.9 and Luciferase activities were determined 
using the Dual-Glo® Luciferase Assay (Promega, WI, USA) in accordance to manufacturer’s 
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protocols, luminescence was assayed on a Synergy 2 microplate reader (Biotek, VT, USA). 
Luminescence intensities for the Renilla luciferase (Rluc ) were normalized against the 
simultaneously examined firefly luciferase (Fluc ). Normalized Rluc / Fluc values were calculated 
according to manufacturer’s guidelines. 
2.1.11 FLUORESCENCE MICROSCOPY AND FLOW CYTOMETRY 
 
Transfected Hek293 cells were evaluated using fluorescence microscopy; pictures were taken 
using an Axio Observer microscope (Zeiss, Jena, Germany). Exposure time was 90 ms for GFP 
(Filter BP 525/50) and 900 ms for RFP (Filter BP 605/70). 
Cells were washed three times with cold PBS, fixed in 2% paraformaldehyde for 45 min and 
washed again in cold PBS and re-suspended in 200 μl PBS; cells were read afterwards or keep at 
4  °C for a maximum of 72 h before FACS analysis.  
 
Flow cytometry was performed using a BD LSR II instrument (BD, New Jersey, USA). The filters 
employed 550LP- BP575/26 and BP450/50 for YFP and CFP respectively. YFP positive cells were 
selected using the FACSdiva™ software and FCS files were exported for analysis in R (See 
Bioinformatics). 
PROTEIN AND RNA BIOCHEMISTRY 
2.1.12 WESTERN BLOT 
Cells were washed twice with cold PBS and resuspended in 150 µL RIPA buffer. Then 50 µL TCA 
added (50 % w/v TCA) and incubated 10 minutes on ice and centrifuged at 13.000 rpm for 5 
minutes at 4 °C and the pellet was washed with 4 volumes cold acetone and centrifuged. The 
pellet was dried out for 10 min at 37 °C and resuspended in Laemmli buffer82 and incubated at 
95 °C for 10 min and loaded on SDS gel.  
Protein separation was performed on sodium dodecyl sulfate (SDS-) gel electrophoresis 83 and 
gels were prepared in NovexTM cassettes according to the following standard recipe: 
Table 5. Recipe for separation gel 
Component Amount (10% gels) Amount (12.5 % gels) 
H2O 2,5 mL 2.19 mL 
40% Acrylamide/bis Acrylamid 1.25 mL 1.56 mL 
1,5 M Tris, pH 8,8 1.25 mL 1.25 mL 
10% ammonium persulfate (APS) 50 µL 50 µL 
TEMED 5 µL 5 µL 
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      Table 6. Stacking gel recipe 
Component Amount 
H2O 3.13 mL 
40% Acrylamide/bis Acrylamid 0.62 mL 
1,5 M Tris, pH 6,8 1.25 mL 
10% ammoniumpersulfate (APS) 50 µL 
TEMED 5 µL 
 
The used ladders were Page ruler pre-stained Protein Ladder (Fermentas, MA, USA) or Magic 
Mark XP protein Ladder (Thermo Fischer, MA, USA), Electrophoresis was performed at 35 mA for 
2 h. Afterward proteins were transferred onto a nitrocellulose membrane using the wet system  
XCell II Blot Module (Thermo Fischer, MA, USA) using 3 Whatman papers and 2 sponges soaked 
in transfer buffer for 1 h at 25 V. Transfer was checked using Panceau red and membrane was 
blocked with NETT-G buffer for 1h at room temperature. 
 Incubated with primary antibody over night at 4 °C and next day membranes were washed 
three times with TBS-T and incubated with HRP coupled anti-Rabbit (G-21234 Life Technologies, 
Carlsbad, USA) diluted 1:10.000 in TBS-T for 2h at room temperature and then washed three 
times with TBS-T. The chemiluminescence signal was developed with HRP substrate (Luminata 
Forte, Merck, Germany) and detected by ECL machine (Chemocam Imager, INTAS, Germany). 
Primary antibodies used were anti-hMTR4 (ab70551 Abcam, Cambridge, UK) at dilution 1:5000 
and anti-FBL (EPR10823(B)Abcam, Cambridge, UK ) at a dilution 1:5000.  
2.1.13 NORTHERN BLOT 
RNA was diluted in 2X Novex TM TBE-Urea Sample Buffer (Thermo Fisher Scientific, MA, USA) 
and incubated for 5 min at 95 °C.  Following separation in 15% Polyacrylamide/Urea gel 
Electrophoresis at 180 V  for 75 min using  the XCell SureLock™ Mini-Cell Electrophoresis System 
(Thermo Fisher Scientific, MA, USA) in TBE buffer.  Transfer into Bright Start Nylon membrane 
was performed using the wet system  XCell II Blot Module (Thermo Fischer, MA, USA) at 25 V for 
30 minutes in 0.5X TBE buffer and the RNA was crosslinked for 3 minutes at 302 nm UV 
transilluminator.  
The hybridization and detection were performed using the North2South® Chemiluminescent 
hybridization and detection kit following manufacturer’s instructions. 1 nM of custom prepared 
LNA biotin labeled probe (Exiqon, (Qiagen, Germany)) at 45 °C in a hybridization incubation 
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chamber and the signal was detected by ECL machine (Chemocam Imager, INTAS, Germany). The 
target  U78 sequence used was UGAGCAUGUAGACAAAGGUAACACUGAA. 
BIOINFORMATICS AND STATISTICAL ANALYSES 
All the bioinformatics and statistical analysis were performed using Biolinux open source84, R 
environment with R studio 85,86 and Bioconductor87. 
2.1.14 NEXT GENERATION SEQUENCING DATA ANALYSIS 
 
2.1.14.1 Ion torrent Data Analysis  
Raw reads were trimmed and quality filtered employing the Ion -Torrent Suite Software (Life 
Technologies, CA, USA). FASTQ outputs from the suite were changed to FASTA format and 
collapsed using FASTX-toolkit (http://hannonlab.cshl.edu/); next collapsed FASTA files were 
aligned to the miRbase v 2188 and snoRNA base v3 89 with Bowtie290 employing the following 
command line arguments: 
-D 15 -R 3 -N 0 -L 16 -k 20 --local -i S,1,0.50 --score-min L,18,0 --ma 1 --np 0 --mp 2,2 --rdg 5,1 --rfg 5,1 
The .fa format files from miRbase and snoRNA base v3 were used to create a mapping database 
with the command bowtie2-build. Then SAM outputs were changed to Blast format using 
sam2blast, later significant hits by E-value were selected using mtophits_blast and duplicates 
were removed with remove_duplicate_hits_blast.pl, scripts were adapted or modified from 
Grzegorz Kudla (https://github.com/gkudla)91.  
Results files (Called here Filtered-Blast) were further analyzed by custom made R-scripts and 
normalization was performed using DEseq package85,92. 
Alignment to the reference genome (Hg19) was performed using the Ion -Torrent Suite Software 
and BAM files were employed for genomic track analyses in IGV genome browser93.  
2.1.14.2 GEO datasets analysis 
 
The GEO data were retrieved using the SRA-toolkit94 and transformed from binaries to FASTQ 
using the fastq-dump tool, all the downloaded libraries were analyzed with FASTQC and just data 
that fit the original publication description were kept. According to the platform and the 
library preparation demultiplexing and adaptor trim were applied using Flexbar95 or 
FASTX-toolkit (http://hannonlab.cshl.edu/), for paired end data the two FASTQ files were 
merged using PEAR96 with the default command line. The data set analyzed were: 
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Table 7. GEO retrived raw data. 
Description GEO 
accession 
number 
Reference Comment 
Hela cellular 
fractionation 
  GSE50057 
 
   (97) Bai et al. Ion Torrent library 
snoRNPs 
Hek293 
GSE43666 (98) Kishore et al.  PAR-CLIP endogenous 
NOP56, 
Fibrillarin,Dyskerin and 
FLAG-NOP58. 
Size selection of small RNAs  
DGCR8 
Hek293 
GSE39086 (99) Macias et al. HITS-CLIP FLAG and 
endogenous DGCR8 
DICER 
Hek293 
GSE55333 (100) Rybak-Wolf et 
al. 
PAR-CLIP FLAG-Dicer1  
Argonaute 
Hek293 
GSE21918 (101) Hafner et al. PAR-CLIP FLAG-AGO 1 to 4 
GSE50452 (30) Helwak et al CLASH Libraries E1, E4 and E7 
GSE58127 (102) Flores et al. RIP and Cellular small RNAs. 
RIP seq of 2 antibodies 
against Argonaute 
 
Filtered and demultiplexed Fastq files were processed as Ion Torrent Fastq file s see 
2.1.14.1. 
2.1.15 GRAPHS GENERATION 
All the graphs were performed in the R environment, if is not otherwise stated, using the default 
graphics and the ggplot2 package97,103  
2.1.15.1 Fraction calculation of mature vs small snoRNAs 
To compare RNA purification methods, 20-200 aligned reads ( in blast format) were subsetted 
according to read length, then separated between (mature and processed) using the threshold 
of 40 nt. Finally, they were compared with the Ion-Torrent libraries. 
 
2.1.15.2 Hierarchical clustering from binary matrices 
To define processing pattern filtered blast files were refined for individual snoRNAs or miRNAs. 
The reported mature or pre-miRNA length was used as column number while each read 
corresponds to a row, forming a matrix of nucleotides as column and reads as rows. For each 
base on the read that matches a position on the transcript; the value 1 was given, while no 
match was set to 0. Creating a binary matrix with columns showing each base on the transcript, 
while rows represent the reads with 1 for bases presence and 0 for absent bases. 
 For more than 100.000 reads the total read number was simplified by calculating fraction of the 
total amount, and multiplied by a 10 multiplier  
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to get a number greater than 1 and transformed into an integer before generating the binary 
matrix. 
The matrix was organized using hierarchal clustering of rows using the hclust command of basic 
R and plot using the Heatmap2 command from gplot package104 
2.1.15.3 Density plots 
To define the density of reads over the transcripts similarly to Grannemann on CRAC analysis105  
Blast files were filtered for individual snoRNAs or miRNAs and transcript size was used as vector 
length. The sum per the column of binary matrices was calculated and replaced in the density 
vector, later the fraction of total number of reads was calculated. Tidy data was generated  for 
each library and RNA, then plotted using ggplots2103   
2.1.15.4 snoRNA chimera calls from CLASH data set 
To called chimeras from CLASH Ago1 data the Hyb pipeline was implemented in Biolinux as recommended 
by the Authors
91
,  snoRNA based chimeras were called using the following command:  
hyb analyse in=data_comp_hOH7.blast format=blast align=none type=sno pref=none hval=0.1 hmax=10 gmax=4 
Blast files were produced as described for Ion-torrent using the default data base in the Hyb pipeline for 
the GSE50452 (libraries E1,E4 and E7). Then the U3 chimeras were collected for the three libraries and 
checked manually.   
2.1.16 ANALYTICAL FLOW CYTOMETRY  
 
2.1.16.1 Simulations and parameters estimation 
 
For small RNA induced regulation in the bacterial system, a randomly generated X  values were 
used as input in a custom wrote R function using Equation 4 and parameters 𝐹𝑟 and    were 
arbitrary  selected.  For miRNA simulation similar approaches was performed but using Equation 
7, then siRNA experiments or endogenous miRNA on Hek293 cells were used to estimate 𝜆 and 
𝜃 by nonlinear (weighted) least squares using Equation 7.  For detailed equation explanations 
and descriptions see 2.1.26.2 
 
Then a new set of simulations were performed using the range of YFP intensities were used for 
simulations; the simulations can be reproduced at 
https://medicalrnabiology.shinyapps.io/pUTApp/ 
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Figure 6 QR code to replicate on line numerical simulation for miRNA titration model. 
 
2.1.16.2 Analytical function generation 
 
Positive YFP cells data was extracted on FCS 2.0 or 3.0 format and transferred into the R 
environment using the FlowCore Bioconductor package 87,106,107. Analytical functions generation 
from raw data was generated similarly to 31,44,108,109. YFP Log transformed relative intensities 
were binned at 0.05 interval, then descriptive statistical values for relative log CFP intensities 
were calculated, all the plots represented here show the average CFP intensity per bin (Figure 
32) 
2.1.17 OTHER STATISTICAL ANALYSIS 
Some Non parametric ANOVA analysis, Dunn`s multiple comparison tests and linear analysis 
were performed using the PRISM software (GraphPad, CA, USA) 
 MATERIALS 
2.1.18 MACHINES 
 
     Table 8: Used machines and manufacturer information 
Machine Model Company 
Balance EG 620-3NM Kern & Sohn GmbH, Germany 
Chemiluminescence System ChemoCam Imager INTAS, Germany 
Centrifuge Heraeus Megafuge 8R Thermo Fisher Scientific, MA, USA 
Centrifuge Heraeus Fresco21 Thermo Fisher Scientific, MA, USA 
Centrifuge Avanti J-30I Beckman Coulter, CA, USA 
E-Gel system E-Gel iBase System Life Technologies, CA, USA 
Fluorometer Qubit 2.0 Life Technologies, CA, USA 
Freezer (-20°C)  Bosch, Germany 
Freezer (-80°C) MDF-DU500VH-PE Panasonic, Japan 
Freezer (-150°C) ULT7150-9-D Thermo Fisher Scientific, MA, USA 
Flow Cytometer LSR II Flow Cytometer BD Bioscience, NJ, USA 
Gel documentation system Gel iX Imager INTAS, Germany 
Hamilton pipette Microliter
TM
 Syringes Hamilton, NV, USA 
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Ice machine ZBE 70-35 Ziegra, Germany 
Incubator Heracell VIOS 160i  Thermo Fisher Scientific, MA, USA 
Incubator IN75 Memmert, Germany 
Incubator Ecotron Infors HT, Switzerland 
Hybridization chamber MS Hybridization oven Major Science Co.Taiwan 
Ion Torrent NGS PGM Life Technologies, CA, USA 
Ion Torrent OneTouch2 OneTouch2
TM
  Life Technologies, CA, USA 
Ion Torrent OneTouch ES OneTouch ES Life Technologies, CA, USA 
Microscope Axio Vert. A1 Zeiss, Germany 
PCR Thermocycler Labcycler Sensoquest, Germany 
PCR Thermocycler 2720 Thermal cycler Applied Biosystems, MA, USA 
pH meter SevenCompact
TM
 S210 Mettler Toledo, OH, USA 
Plate Reader Synergy 2 BioTek, VT, USA 
Platform Rocker PMR-30 Grant bio, Cambridge, UK 
Power supply EV231 Consort bvba, Belgium 
Safety Cabinet Safe 2020 Thermo Fisher Scientific, MA, USA 
Thermoblock ThermoStat plus Eppendorf, Germany 
Thermoblock CTM HTA-BioTec, Germany 
Vortexer Vortex-Genie
TM
 2 Scientific Industries, NY, USA 
Water bath WNB10 Memmert, Germany 
Western Blot chamber XCell SureLock® 
MiniCell  
Life Technologies, CA, USA 
 
2.1.19 BUFFERS AND SOLUTIONS 
 
   Table 9: Information about buffers and solutions 
 
Buffer and solutions Recipe 
Electrophoresis buffer (SDS-PAGE) (10x) 250 mM Tris 
1,9 M Glycin 
1 % SDS 
Laemmli buffer 0,125 M Tris-HCl pH 6,8 
4 % SDS 
20 % Glycerol 
10 % 𝛽-Mercaptoethanol 
0,004 % Bromphenolblau 
LB media Yeast extract (5 g/L) 
Trypton (10 g/L) 
NaCl (5 g/L) 
RIPA buffer 25 mM Tris-HCl pH 7,6 
150 mM NaCl 
1 % NP-40 
1 % Natrium-Deoxycholat 
0,1 % SDS 
TAE buffer (Agarose gel electrophoreses) 40 mM Tris-HCl  
20 mM acetic acid  
1 mM EDTA  
pH 7,0 
TBS 500 mM Tris  
1,5 M NaCl 
pH 7,6 
TBS-T 500 mM Tris  
1,5 M NaCl 
0,05 % Tween20 
Western blot blocking buffer (NETT-G) 1 L NETT (1 x) 
0,25 % Gelatine 
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Western blot transferbuffer 12 mM Tris 
96  mM Glycin 
20 % Methanol 
Western blot wash buffer (NETT, 10x) 1,5 M NaCl 
0,05 M EDTA pH 8,0 
0,5 M Tris-HCl pH 7,5 
0,5 % Triton X-100 
Northern blot (TBE) 89 mM Tris base 
89 mM Boric acid 
2 mM   EDTA (Free acid) 
pH 8.3 
Buffers and solution non-stated in methods. 
 
2.1.20 CHEMICALS AND MATERIALS 
 
            Table 10. Chemical and materials 
Compound Provider Information Compound Provider Information 
0,45 µm filter Sigma Aldrich, MO, USA Hydrochloric acid(37%) Carl Roth, Germany 
1,4-Dithiothreitol Carl Roth, Germany Hydrogenperoxid Urea Merck, Germany 
24-well plate Greiner, Germany Imidazol Sigma Aldrich, MO, USA 
2-propanol Merck-Millipore, Germany IPTG Carl Roth, Germany 
6-well plate Greiner, Germany Isopropanol Carl Roth, Germany 
96-well plate Greiner, Germany Kanamycin Applichem, MO, USA 
Acetic acid Carl Roth, Germany L-Ascorbic acid Sigma Aldrich, MO, USA 
Aceton Carl Roth, Germany Kanamycin Applichem, MO, USA 
Acrylamid (40%) Bis 
solution  
Biorad Ca, USA L-Ascorbic acid Sigma Aldrich, MO, USA 
Acrylamid solution Carl Roth, Germany Loading Dye (DNA) Thermo Fischer, MA, USA 
Agar-Agar Carl Roth, Germany MagicMarkTM XP Protein 
Marker  
Invitrogen, CA, USA 
Agarose Biozym, Austria Methanol Carl Roth, Germany 
Agarose (LE Agarose) Carl Roth, Germany Methylenblue Carl Roth, Germany 
Ammonium persulfate 
(APS) 
Sigma Aldrich, MO, USA 
MOPS Carl Roth, Germany 
Ammoniumchloride Carl Roth, Germany Nitrocellulose membrane Macherey-Nagel, Germany 
Ammoniumperoxodisulfa
t (APS) 
Carl Roth, Germany 
Paraformaldehyde Carl Roth, Germany 
Ammoniumsulfate Carl Roth, Germany PBS-Dulbecco PAA, MA, USA 
Ampicillin Carl Roth, Germany Penicillin/streptomycin PAA, MA, USA 
β-Mercaptoethanol Carl Roth, Germany Petri dishes Greiner Bio-one, Austria 
Biotherm Taq Genecraft, Germany PhenolRed Carl Roth, Germany 
Biotherm Taq 10x buffer  Genecraft, Germany Pipette tips 10µL Eppendorf, Germany 
Bordeaux Red Sigma Aldrich, MO, USA Pipette tips 1000 µL Eppendorf, Germany 
Boric acid Sigma Aldrich, MO, USA Pipette tips 200 µL Eppendorf, Germany 
  Ponceau Red Sigma Aldrich, MO, USA 
Bromphenol Sodium salt Carl Roth, Germany Potassium hydroxyide Carl Roth, Germany 
Calciumchloride 
(Cellpure) 
Carl Roth, Germany Potassium sodium tartrate 
tetrahydrate 
Sigma Aldrich, MO, USA 
Chloroform Merck Millipore, Germany Potassiumchloride Carl Roth, Germany 
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Complete Mini Roche, Switzerland Potassium-di-
Hydrogenphosphate 
Carl Roth, Germany 
Cryokonservation tubes Sarstedt, Germany Reaction tube 1,5 mL  Eppendorf, Germany 
di 
Sodiumhydrogenphospha
te 
Carl Roth, Germany 
Reaction tube 2 mL Eppendorf, Germany 
Diethyl pyrocaronate Sigma Aldrich, MO, USA RNA later solution Ambion, MA, USA  
Dimethylsulfoxid  Roth, Germany RNase Sigma Aldrich, MO, USA 
diPotassiumhydrogenpho
sphate 
Carl Roth, Germany 
SDS-Pellets Carl Roth, Germany 
D-L-Lysine Sigma Aldrich, MO, USA Serological pipette 10 mL Sarstedt, Germany 
diPotassiumhydrogenpho
sphate 
Carl Roth, Germany 
Serological pipette 25 mL  Sarstedt, Germany 
dNTPs Sigma Aldrich, MO, USA Serological pipette 5 mL Sarstedt, Germany 
Ethanol Merck-Millipore, Germany Tetracyclin Hydrochloride Carl Roth, Germany 
DTT Carl Roth, Germany Tetramethylethylenediami
ne (TEMED) 
Sigma Aldrich, MO, USA 
EDTA Applichem, MO, USA Tris acetate Carl Roth, Germany 
EGTA Sigma Aldrich, MO, USA TRIS base Sigma Aldrich, MO, USA 
Ethanol Merck-Millipore, Germany Tris-HCl Sigma Aldrich, MO, USA 
Ethidiumbromide Carl Roth, Germany tri-Sodiumcitrate diHydrate Carl Roth, Germany 
Falcontube 15 mL Greiner Bio-One, Austria Triton X-100 Sigma Aldrich, MO, USA 
Falcontube 50 mL Greiner Bio-One, Austria Trypanblue PAA, MA, USA 
Fetal calf serum Gibco, MA, USA Trypsin-EDTA PAN, MA, USA 
Glycerol Sigma Aldrich, MO, USA Tween 20 Carl Roth, Germany 
HCL solution  Merck-Millipore, Germany Whatman Paper Carl Roth, Germany 
HEPES Carl Roth, Germany X-Gal Carl Roth, Germany 
HPLC-Wasser Millipore-Merck, Germany Yeast Carl Roth, Germany 
 
2.1.21 BACTERIAL STRAINS INFORMATION 
 
Table 11. Bacterial strains 
Strain Genotype Source 
One Shot® Stbl3™ Chemically 
Competent E.coli 
F-mcrB mrrhsdS20 (rB-, mB-) recA13 
supE44 ara-14 galK2 lacY1 proA2 
rpsL20 (StrR) xyl-5 λ-leumtl-1 
Thermo Fisher 
Scientific, MA, USA 
C737303 
 
One Shot® TOP10 Chemically 
Competent E.coli 
F- mcrA Δ (mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 
araD139 Δ( araleu)7697 galU galK rpsL 
(StrR) endA1 nupG 
Thermo Fisher 
Scientific, MA, USA 
C404010 
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2.1.22 CELL LINES 
 
Table 12. Mammalian cell lines 
Cell line Description Distributor information 
HEK293 Human embryonic kidney (ATCC® CRL-1573TM) 
HeLa  Human cervix carcinoma (ATCC® CCL-2TM) 
 
2.1.23 CELL CULTURE MEDIA AND ADDITIVES 
 
Table 13. Mammalian Cell culture Media 
Medium Additives Company 
DMEM + L-Glutamine, + phenol red, high glucose Gibco 
Optimem + L-Glutamine, + phenol red Gibco 
DPBS No Ca, no Mg, no phenol red PAN 
Fetal calf serum Heat inactivated Gibco 
RPMI + L-Glutamine, + phenol red Gibco 
Trypsin 0,05 % in PBS, no Mg2+, no Ca2+ PAN 
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RESULTS 
NGS CHARACTERIZATION OF SNORNA-DERIVED MIRNAS 
 
To functionally characterize C/D snoRNA-derived miRNAs  (C/D-miRNAs) I used two 
experimental approaches: first using high-throughput derived data I described miRNAs 
structure, distribution, and interaction with RNA binding proteins. Secondly, I created a high-
resolution assay to test miRNA functionality and applied it to supposed C/D-miRNAs.   
Figure 7 outlines the experimental procedure I used to generate NGS raw data. For structure and 
expression, I sequenced small RNAs from Hek293 using the Ion-Torrent platform, while for RNPs 
interaction I retrieved raw data from CLIP and RIP-seq experiments available in the Gene 
Expression Omnibus110. Later, I filtered, trimmed and demultiplexed the FASTQ files and reduced 
PCR duplicates by collapsing identical reads.  
 
Figure 7. NGS Characterization of snoRNA-derived miRNAs.   
Experimental outline of small RNA characterization: Hek293 cells were used for Ion-Torrent 
libraries to evaluate cellular RNA content, while RAW data from GEO database was retrieved 
using the terms Hek293 cells and RNA immunoprecipitation. Then FASTQ files were 
preprocessed, collapsed and mapped to snoRNA and miRNA transcripts data base to further 
analysis.  
2.1.24 SNORNA-DERIVED MIRNA CHARACTERIZATION FROM SMALL RNA LIBRARIES. 
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2.1.24.1 snoRNA-derived miRNA characterization from Ion-Torrent NGS platform. 
 
Since I am interested in snoRNAs-miRNAs and in reducing computing time, I aligned the 
collapsed FASTA files to a miRNA-snoRNA databases rather than the whole genome*1, preferring 
an analysis of individual candidates analogously to Granneman reports of U3 in CRAC analysis 111. 
To select the C/D-miRNA candidates, I chose the top five highest expressed snoRNAs with 
coherent processing; for that reason, I sequenced three independent Hek293 cultures. To assure 
that I operate with reduced degradation bias, I just used high-quality RNA (RIN > 9) to prepare 
and to sequence libraries using the Ion-Torrent platform. (Supplementary Figure 1). 
The three sequenced libraries show a high correlation between expressed small-RNAs (Figure 8 
A) and the top 30 identified miRNAs cluster together - being L001 and L004 closer (Figure 8 C) 
and this is consistent with their Pearson correlation coefficient.  Their read length distributions 
show a high peak at 21 to 22 nt with a mild peak around 60 to 70 nt (Figure 8 B), these two 
peaks correspond to miRNAs and snoRNAs respectively, these two peaks match to miRNAs and 
snoRNAs respectively, as shown in the fraction of recovered small RNA. (Figure 8 D) 
Additionally the small-RNA seq yield similar patterns as other platforms (For details look next 
section). 
To define C/D-miRNAs, I subsetted snoRNA reads by length, and classified snoRNAs in two:  
mature, with reads longer than 40 nt (Figure 9 A), and C/D-miRNA as sequences below 40 (Figure 
9 B); the top expressed genes show dissimilar distribution between long and small snoRNAs.  
To rule out that the C/D snoRNAs are degradation remnants rather than stable miRNAs; called 
here coherently processed112. I checked snoRNAs read distribution on genomic tracks 
(Supplementary Figure 2 A), but this require complicated and time consuming manual inspection 
of genome aligned reads. 
To simplify and automatize this procedure, I employed hierarchical clustering analysis to classify 
snoRNA processing using binary matrix. Concisely I calculated the binary matrix using the 
transcript length as columns, and the reads as rows.  Since every read has defined start and end, 
                                                          
*1 Genomic alignments were performed and used to analyzed processing patterns, see hierarchal clustering below.    
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each position in the transcript has a value 1, while 0 designates no read at that particular site; 
creating the binary matrix.  
 
A  
 
B 
 
C 
 
Figure 8. small RNA seq libraries reveled expected distribution for snoRNA and miRNAs. 
Small RNA from three independent Hek293 cultures were purified, subject to library 
preparation and sequenced.  Analysis of small RNA content from the three samples: (A) small 
RNA content comparison, each dot in the scatter plot represents log10 transformed reads -
Pearson Coefficients L001 vs. L004 R= 0.979, L001 vs. L007 R=0.969. (B - C) Read size 
distribution and hierarchal clustering from normalized read counts. (D) miRNA and snoRNA 
(C/D snoRNA, scaRNA, and H/ACA) fraction. 
To simplify and automatize this procedure, I employed hierarchical clustering analysis to classify 
snoRNA processing using binary matrix. Concisely I calculated the binary matrix using the 
transcript length as columns, and the reads as rows.  Since every read has defined start and end, 
each position in the transcript has a value 1, while 0 designates no read at that particular site; 
creating the binary matrix.  
D 
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Therefore, a binary matrix has columns as nucleotides in the transcript and number of rows 
equal to reads aligned to it. For example, a U78 array will have 65 columns and around 200 rows 
for the Ion-Torrent libraries (Figure 9).   
Hierarchal clustering analysis (HCA) arranges similar observations sequentially, grouping small 
groups until it reaches a single batch113.  
I assumed that coherent processing should create clear clusters, and define the patterns of 
processing or RNP protection. Supplementary Figure 2 shows reads before and after HCA. The 
HCA of the top expressed snoRNA shows three clusters: the mature snoRNAs occupying the 
whole transcript and the derived miRNAs (“passenger” and “guide” strands74). Showing that HCA 
defines quickly the processing of snoRNAs. *2 
                                                          
*2 Candidate selection (See Figure 10 and Figure 11) was also performed manually; using genomic tracks inspection IGV 
genome browser with an average time of 20 to 30 min per snoRNA. Binary matrices, hierarchal clustering and graphical output (in R 
functions) requires an average of 1 minutes for all the snoRNA of Ion-Torrent libraries.  
A 
 
Figure 9 snoRNA-derived miRNAs expression differs from mature counterparts 
snoRNAs reads were dived into groups: Mature snoRNAs (length >40) and snoRNA-derived 
miRNA RNAs (length >40) and descending organized. Boxplot of the 20 most expressed (A) 
mature snoRNAs and (B) derived miRNA normalized reads plotted without transformation. 
B  Read Length < 40 
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C/D-miRNA clusters drop into two distinct groups: 1. processed, which have short leaves and 
clusters with defined long branches, and 2. degraded, holding long leaves and don't coerce in a 
specified node, compare cluster trees of U78 vs. U45A. I decided then, to further analyze just the 
processed C/D miRNAs. 
Small RNA profiling recover defined patterns of miRNAs that match the guide or the passenger 
strand, with the first being mostly recovered.  For the candidates that filled the processed group, 
I observed a similar trend (Figure 10) and because the H/ACA derived miRNAs ACA45 passed the 
initial examination, and it is the first group VI well-characterized miRNA4, I integrated it as 
snoRNA-derived miRNA control. 
 
 
Figure 10 Reads hierarchical clustering analysis sorts snoRNA-processing patterns 
To contrast with genomic tracks analysis (Supplementary Figure 2), snoRNA reads transformed 
into binary matrices were subjected to hierarchical clustering analysis, cluster tree and reads 
over the snoRNA transcripts (blue bars) plots from the most expressed snoRNA- miRNAs.  
Moreover, I compared the length distribution for the C/D-miRNAs with canonical miRNAs; I 
found that H/ACA-45 and the miRNAs range are below 25 nt, with a median of 22 and 19 
respectively. For the C/D derived miRNAs, U78, U44, U74, and snRN39 ranges are longer than 
25, while U3 derived miRNA drop into controls range (Figure 11).   
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A 
 
B 
 
Figure 11. snoRNA-derived miRNA show heterogeneous processing. 
Top 5 expressed snoRNA-derived miRNA analysis: (A) expression as boxplot of untransformed 
normalized reads and processing clusters for C/D snoRNA-derived miRNA (U78, U44, snRN39, 
U3), and H/ACA snoRNA-derived miRNA  (ACA45), (B) Read length distribution. The Graph 
shows the read length, read position in the transcript and the red line separates them in two 
groups -small RNAs lower and higher than 25 nucleotides.  
Finally, I wanted to see the C/D-miRNAs without the library preparation bias; so I performed 
small RNA northern blot for the most expressed C/D miRNA U78 (Figure 11 A).  To optimize the 
experimental condition that could detect RNA, corresponding to 200 reads on Ion-Torrent 
(approximately one pg per microgram of total RNA)*3, I used a synthetic RNA as control 
Supplementary Figure 4. I ran total RNA and observed a signal in the same region as the 
synthesized control Figure 12. 
 
                                                          
*3 Rough calculation from total aligned reads (~ 350.000) and small RNA input (~ 100 ng), assuming linear relation 200 reads 
corresponds to 57 pg. 
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A 
 
Figure 12. U78 derived miRNA detection by 
northern blot.   
Decreasing concentrations of Hek293’s total 
RNA were separated in a 15% UREA-PAGE, 
transferred to a nylon membrane and 
incubated at with the probe at 45 C for 16 h.   
A synthetic RNA, which contains the most 
expressed snoRNA-miRNA sequence, was 
used as reference.  (A) Graphical 
representation of U78 C/D snoRNA and the 
used probe (B) Ethidium bromide stain and 
northern blot results for mature and snoRNA-
derived miRNA. 
 
 
 
 
 
 
B 
 
2.1.24.2 Comparison between small RNA purification methods: small RNA libraries 
yield of mature snoRNAs. 
 
 C/D snoRNA miRNAs are unlikely to be library preparation artifacts, and probably produced 
independently from the mature forms ( Figure 9 ). However, I presumed that Ion-Torrent profiles 
might be biased since the purification protocol is optimized for miRNAs, the read-length 
distribution shows more miRNAs than snoRNAs (Figure 8 A), which contradicts the assumption  
that for ribosome biogenesis snoRNAs should be abundant. 
To compare methods and rule this bias out, I searched for Hek293 data sets in the GEO 
repository and I found two Illumina libraries produced with distinct purification methods 
(GSE43666). The original experimenters generated two small RNA pools: one for miRNAs (18-30) 
and others for small RNAs (20-200). Figure 13 contrasts the performed procedures. 
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Figure 13. Outline of raw data recovery for size separated RNA. 
Comparison of ethanol and PAGE based RNA separation for small RNA libraries for Ion Torrent 
and Illumina NGS sequencing, the cartoon depicts the source from cell culture and GEO raw 
data for Hek293 cells, the method of purification, the expected size, and the sequencing 
platform. 
I processed the FASTQ files, aligned them to the snoRNA-miRNA database, and compared them 
with my Ion-Torrent libraries; I observed a positive correlation between the three data sets with 
a higher Pearson coefficient (R=0.68) between the Ion-Torrent and the 18-30 nt Illumina libraries 
(Figure 14 A). The small-RNAs comparison relates the read length distribution and the 
purification method, whereas the 20-200 nt shows peaks around 21 and 70 the Ion Torrent has a 
smaller one around 70  (Figure 14 B); implying that Ion-Torrent profiles do not characterize 
properly mature snoRNAs. 
Since the libraries correlate, and the 20-200 produced library has the proper small RNA 
distribution, I looked at the relationship between mature snoRNAs and the C/D-miRNAs. 
Calculating the fraction (mature-miRNA) for each C/D snoRNA, i.e., if a snoRNA has 10 miRNAs 
and 90 long reads, the fraction will be 0.1 and 0.9 respectively.  
The whole C/D snoRNA population shows that the C/D miRNAs (processed) are below 0.2 and 
that recovered reads are mature forms (Figure 14 C). The expression relationship, between long 
and short snoRNAs, show a positive correlation for both, 18-30 and 20-200 nt, implying that the 
mature snoRNA are the source of miRNAs.  
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Figure 14. snoRNA-derived miRNAs content is lower than mature snoRNAs and their 
expression positively correlates.    
Expression comparison of small RNAs libraries: Ion Torrent  (generated here) and retrieved 
Illumina (GSE43666 18-30 and 20-200) raw data analysis. (A) Scatter plot of log transformed and 
normalized reads (Pearson Coefficients Ion-Torrent vs. 18-30 R=0.68 and Ion-Torrent vs. 20-200 
R=0.49) and (B) Read length distribution between libraries.  Expression of snoRNA-derived 
miRNAs compared with mature snoRNAs. (C) Boxplots depict mature vs micro snoRNAs fraction 
from each C/D snoRNA in the 20-200 Illumina library.  (D) scatter plot 20-200 mature vs. 
snoRNA-derived miRNAs library (18-30 green) and a subset (< 40 read length blue)  20-200 
library. 
Overall, the purification methods yield different small RNA subpopulations, and interpretations 
about mature snoRNA from miRNA-focused analysis require caution. But to falsify the claim 
“C/D miRNA works as canonical miRNAs”, any library either Illumina or Ion-Torrent for miRNAs is 
appropriate for interpretation. 
2.1.24.3 snoRNA-derived miRNAs subcellular location.  
To evaluate the cellular fraction of C/D miRNAs, I found at the GEO repository a data set for 
cellular fractions produced from Hela cells (GSE50057). To validate this data, together with Dr. 
Böker we sequenced and analyzed small RNA libraries from total RNA in Hela cells (Figure 15 A), 
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using the same RNA purification and library standards applied to Hek293 cells (Supplementary 
Figure 5). 
Our Hela data is equal to the retrieved GEO libraries since all the libraries positively correlate 
(Figure 15 A and Supplementary Figure 5), and the processing clusters for ACA45, U3, U78, U44, 
U74, and snRN39 resembled the Hek293 (data not shown). I analyzed their subcellular 
percentage for the whole small RNA population and selected candidates (Figure 15) 
The location percentages show that miRNAs locate at the cyto- and nucleoplasm, while the C/D 
snoRNAs mainly at nuclear compartment, which is right for U78, U44, U74, and snRN39. 
Interestingly, I found ACA45 and U3 miRNAs in the cytoplasmic fractions, while ACA45 shows the 
higher percentage, U3 is lower than its nuclear and nucleolar location ( Figure 15 D). 
 
 
Figure 15. snoRNA-derived miRNAs  locate in the nucleolus 
Raw data -from cellular fractionations (GSE50057) and Ion-torrent data from Hela cells (kindly 
provided by Dr. Böker, Medical RNA Biology) were analyzed for snoRNA-derived miRNAs. (A) 
Outline of the experimental approach for fractionation. (B) Scatter plot compares whole 
cellular content libraries Böker vs. GSE50057  (Pearson Correlation R). The fractions of small 
RNA between cytoplasm, nucleus, and nucleolus. (C) miRNA and snoRNA-derived miRNAs 
depicted as a heat map and (D) for selected candidates.  
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Until now, I pointed out that: 
 C/D snoRNAs loci produce RNA fragments of approximately 25 nt. 
 C/D small fragments depict guide-passenger relationship in their locus in sRNA seq.  
 C/D miRNAs are lower than their canonical counterparts (mature snoRNAs) 
 C/D miRNAs locate in the nuclear and nucleolar fractions. 
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2.1.24.4 snoRNA-derived miRNAs characterization from RIP and CLIP seq. 
 
Figure 16. CLIP and RIP-seq analyzed data.  
To check snoRNA-derived miRNAs interaction with ribonucleoproteins, GEO raw NGS data for 
Hek293 was retrieved. Cartoon depicts analyzed selected proteins, snoRNPs-Nop58, Nop56, and 
Fibrillarin (GSE43666) and miRNPs, -Dcrg8 (GSE39086), Dicer (GSE55333) and Argonaute (CLASH-
GSE50452, PAR-CLIP GSE21918, and RIP GSE58127). 
 
After I had evaluated the cellular C/D miRNAs, I decided to check the interaction with 
ribonucleoproteins, using again predictive the predictive power of scientific paradigms. We can 
define the following conditional predictive statement:  if C/D-miRNAs functional activity mirrors 
canonical miRNA post-transcriptional regulation, they should be pulled down concomitantly with 
Argonaute proteins and interact with the miRNAs maturation machinery.  
For that reason, I retrieved GEO repository data from RIP and CLIP-seq raw data for Hek293 cells 
and miRNAs, after specific preprocessing and PCR duplicates removing (due to different library 
preparation), I aligned it to snoRNA and miRNA databases and examined individually for  U78, 
U44, U74, and snRN39.  For purposes explained below (2.1.24.7), I also recovered data for C/D 
snoRNPs. Figure 16 presents the obtained data and contains the respective accession numbers. 
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2.1.24.5 Argonaute PAR and CLIP seq recover U3 and ACA45. 
 
Figure 17. Hek293 small RNA, RIP and CLIP libraries recover comparable miRNA profiles.  
Aligned reads to snoRNA and miRNA database were normalized using DESEQ2 package. 
Heatmap depicts the 100 most expressed genes from the analyzed libraries, including Ion-
Torrent small RNA libraries sequenced in this study (L001, L004, L007). For retrieved raw data, it 
depicts, RIP-seq (Total small RNA -LT cells and two different Ago antibodies  - LEdio for 
diogenade and LEAB for Abcam), CLASH (LE1, LE4 and LE4.2),  PAR-CLIP (TusAGO 1-4) and 
Illumina small-RNA for 18-30 (LT). 
To select good quality data and to take out any introduced bias by different sequencing runs 
and experimenters. I reasoned that the miRNA content from Ion-Torrent profiling (see 2.1.24.1) 
should highly correlate (Pearson Correlation R >  0.5) with  Argonaute RIP- CLIP data and 
possess a weak variation in their expression.  
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Before preprocessing, I ran FASTQC in all the raw FASTQ files and selected just the data that 
gave overall good quality and that the overrepresented sequences fit the reported adapters 
and multiplexing; surprisingly, few-data sets full filled this criterion (data not shown).  
Six data sets from Hek293 cells were consistent with FASTQC reports and published details: 
Three RIP-seq and small RNA Illumina libraries (GSE58127) and three AGO1 CLASH data (GSE 
50452), the FASTQC results from PAR-CLIP GSE21918 failed the quality test. However, I filtered 
all the bad quality reads, because it has the CLIP data from the four AGO isoforms.  
 
The Argonaute pulldowns, Ion torrent, and small RNA sequencing positively correlate 
(Supplementary Figure 7), and the top 100 miRNAs expression is constant among the libraries. 
Unsupervised analysis clusters the samples according to their source (Figure 17); the group 
 
Figure 18. Argonaute CLIP and RIP identifies 3 bound snoRNA-derived miRNAs 
    Argonaute immunoprecipitated data comparison.(A) Scatter plot showing read normalized 
transformed reads and the mean of biological replicas for each dataset. Colored dots show the 
snoRNAs bound in all the Argonaute: ACA45, U3 and scaRNA 9. Hierarchal clustering for 
recovered snoRNAs, (B) Cluster tree and reads (green) over the snoRNA transcripts. 
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between LT (Illumina 18-30) and Ion-Torrent supports the high correlation observed before 
(Figure 14). 
In total, I analyzed 9 Argonaute pulldowns and decided to be extremely stringent sorting out 
C/D miRNA-Ago interactions. So, I considered valid RNA-Ago only the RNAs recovered in the 
nine libraries, and noted only three snoRNAs U3, ACA45, and SCARNA9 (Figure 18 A). 
To compare the small RNA distribution with the cellular libraries I ran hierarchal clustering of 
Ago binary matrices and observed similar processing clusters (Fig 12 B) for U3 and ACA45; I 
neglected SCARNA9 for further analysis because it wasn't recovered before (Section 2.1.24.1). 
2.1.24.6 Dicer and DGCR CLIP seq recover C/D snoRNAs. 
For Dicer analysis, I found PAR-CLIP data in Hek293 cells that passed FASTQC quality filter and I 
analyzed three biological replicates. Interestingly, U3 appeared within the top 5 and is the most 
recovered C/D snoRNA (Figure 19A and B), while ACA45 appeared just in one biological replicate 
(~20 reads).  
 
Figure 19. Dicer PAR-CLIP recovers U3 snoRNAs fragments.   
Hek293 small-RNA recovered from Dicer PAR-CLIP comparison of three biological replicas. (A) 
5 Top retrieved small-RNAs normalized and transformed reads. (B) Small RNA Fractions for 
the three replicates and a subset for C/D snoRNAs. (C) U3 and miR 20a Hierarchal clustering, 
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cluster tree and reads (green) over the RNA transcripts. 
Processing clusters for U3 showed two main groups: one located as in Ago pull downs (position 
45 to 67)(Figure 19 C and Figure 18 B) and the other upstream with few connecting sequences, 
similarly to the distribution observed in miRNAs112 and (Figure 19 C). 
Finally, I retrieved data from the microprocessor component DGCR8 HITS-CLIP, for endogenous 
and overexpressed protein and I found all C/D miRNA candidates (U78, U74, ACA45 and U3), and 
a relatively big number of snoRNAs (Figure 20 A and B).   
 
Figure 20. DGCR8 HITS-CLIP recovers snoRNA and miRNAs.  
Endogenous and FLAG expressed DGCR8 recovered small RNAs, (A) scatter plot of normalized-
transformed reads, colored dots show snoRNA subpopulations. (B) The fraction of small RNA for 
endogenous and FLAG-immunoprecipitated RNA, (C) Hierarchal clustering, cluster tree and reads 
(green) over the RNA transcripts of top 5 expressed snoRNA-derived miRNAs selected before 
(Figure 11). 
DGCR8 processing clusters resemble C/D-miRNA from cellular small-RNA profiling (Figure 11); 
U78, U44, and ACA45 retrieved groups are similar to the putative guide strands, while U3 
clusters show similar distribution between the 5' and 3' C/D miRNAs (Figure 20  C).  
I noticed that the C/D snoRNA DGCR8 resembles the C/D miRNA-processing clusters, and since 
small RNA recovered from total RNA reflects RNA-RNP protection from nucleases either by AGO 
or Dicer114, I asked whether the small RNA profiling show RNP protection of snoRNAs by RNPs 
different from miRNPs. 
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2.1.24.7 snoRNP CLIP seq recover similar patterns  C/D snoRNA-derived miRNA 
clusters. 
I questioned how does sRNA-seq recover these processing patterns?  
So if Argonaute pulldowns do not enrich intronic snoRNAs and that coherent processing 
retrieved in small RNAs profiling mirrors RNPs interaction (typically for miRNAs), then other RNP 
interaction should explain the coherent process of C/D derived miRNAs. Thus, I retrieved and 
analyzed PAR-CLIP data of snoRNPs 
A significant number of recovered RNAs are C/D snoRNAs; their expression is even between 
replicates and snoRNP, confirming that the data is technically and biologically reliable (Figure 21 
A and B). 
 
Figure 21. snoRNPs PAR-CLIP recover known snoRNAs.  
Profiles of snoRNAs recovered from PAR-CLIP of snoRNA-derived miRNAs (A) Heatmap and (B) 
small RNA fractions from the PAR-CLIP seq libraries. Density graphs show reads position as a 
function of percentage of maximum (Read count/Maximum read in the transcript); U78, U44, 
U74 and U3 are plotted.  
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In detail, C/D snoRNPs (Nop56, Nop58, and Fibrillarin) pull together C/D  snoRNAs, while 
Diskeryn does it for H/ACA and scaRNAs (Figure 21 B). To display the similarity between the 
samples, I replicated Granneman CRAC data display111, generating density plots that have the 
nucleotide position as a function of normalized reads (using percentage of maximum). The C/D 
snoRNAs distributions are similarly within snoRNPs, and the read length recovery resembles 
processing clusters of Ion Torrent profiles, including canonical C and D boxes, but also complete 
snoRNAs (Figure 21 C-F).      
Finally, to test whether the processing clusters in Ion-Torrent profiles reflect in vivo RNP 
protection, I compared C/D-miRNA from cellular RNAs with the one snoRNP and DGCR8 -known 
to interact with snoRNAs and to work as an adaptor for the nuclear exosome.  
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The density plot from RNP and cellular reads overlapped, for U44 the overlay is complete, for 
U78  the overlap is perfect for DGCR8 and partial for Nop56 and U74 recovery has no obvious 
overlap between RNPs and the Ion-Torrent Profile (Cellular)(Figure 22).   
 
Figure 22. Nop56 and DGCR8 snoRNA recovery resembles snoRNA-derived miRNA clusters. 
Selected candidates for intronic C/D snoRNAs U74, U44, and U74, identified for snoRNA-derived 
miRNAs recovery. Density plots depict the distribution for Nop56, DGCR8, and small cellular 
RNA.  Graphs show Reads position in function of the Fraction maximum, (Read count/Maximum 
read in the transcript). 
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Figure 23. snoRNP and miRNPs  CLIP-seq recover U3 and ACA45. 
Reads distribution for snoRNPs and miRNPs CLIP-seq. (A) Canonical distribution of miRNPs and 
cellular recovered on miR-30a transcript, (B) ACA45 distribution of Dyskerin and miRNPs, and (C) 
U3 identified reads from miRNPs and snoRNPs, Density graphs show reads position in function of 
the Fraction maximum, (Read count/Maximum read in the transcript) 
So far, I described that the snoRNA loci produced miRNA size fragments, with a structure that 
resembles the guide and strand guide recovery of miRNAs; pointing out that their central 
location is nucleolar and that they are not bound to Ago but with the microprocessor unit 
DGCR8. However, I found two candidates that do not fit those characteristics, one that serves as 
control ACA45, reported and well proved H/ACA snoRNA-derived miRNA, and U3, that is a C/D 
snoRNA but evolved with distinct function and expression. 
 
 
 
However, I found two candidates that do not fit those characteristics, one that serves as control 
ACA45, reported and well proved H/ACA snoRNA-derived miRNA4, and U3, that is a C/D snoRNA 
but evolved with distinct function and expression. 
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U3  is not intronic and larger than the average C/D snoRNA (217 vs. 70 nt), interact with the 
classic snoRNPs and with the particular U3 protein (U3-55K) 115,116. It also has an intricated 
protein network and location during its biogenesis and is necessary for the early cleavage of the 
5' ETS (see 1.1.3.2).  
CLIP data showed that ACA45 interacts with Argonaute, DGCR8 and poorly with Dicer (~20 reads 
in one replicate), while its interaction with Dyskerin recovered a different pattern; resembling 
canonical miRNAs (Figure 23 A and B). 
Retrieved and analyzed U3 CLIP data display two distinct densities. miRNPs (Ago, Dicer, and 
DGCR8) recovered the 5' domain; this region that interacts with the 18S  and the 5' ETS of the 
pre-rRNA (Figure 23 D Meanwhile, the snoRNPs densities enhanced the 3' domain that holds the 
C', D, C and B boxes  (Figure 23 C).  
In summary, all this evidence exposed my inability to deny U3 snoRNA as a source of canonical 
miRNAs using NGS derived data. Consequently, I concentrated on U3 5' domain to disprove its 
functions as miRNAs using other experimental approaches and predictions inferred from the 
canonical miRNA paradigm. 
2.1.24.8 snoRNP recovers ACA45 and U3 derived miRNAs 
Surprisingly, zooming into the U3 5' domain, the sequences recovery from Dicer follows the 
typical guide and passenger strand structure of miRNAs, including a drop in the density that 
could be the loop in a hairpin substrate. Furthermore, the RNA folding analysis yielded a hairpin 
structure that matched Dicer U3 5' domain PAR-CLIP density (Figure 24 A and B) and the guide 
strand predicted by a trained shRNA expert (Dr. Gruber personal communication), fit with the 
recovered by Argonaute CLIP data. 
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Figure 24. U3 snoRNA 5’-domain interacts with miRNPs 
Read distribution in U3 5' domain from miRNPs CLIP-seq and cellular data, (A) Read position as 
a function of the fraction maximum,U3 5' sequence motifs are depicted in colors. (B) Details of 
the folded 5‘ domain, guide, and passenger strand are drawn according to Dicer and Ago 
recovered profiles. 
Briefly, I could not rule U3 out as a source of miRNAs, while I could show it here for the selected 
intronic C/D snoRNA. For that reason, a high-resolution tool is necessary to detect U3 
endogenous miRNA activity, and to deny its posttranscriptional repression in vivo. 
To this point I reported for C/D snoRNAs that: 
 The snoRNA loci produced miRNA size fragments, with a structure that resembles the 
guide and strand guide recovery of miRNAs. 
  C/D-miRNAs are nuclear and nucleolar.  
 C/D-miRNAs are not bound to Ago but with the microprocessor unit DGCR8. 
 U3 C/D snoRNA-derived miRNAs are bound to Ago, Dicer and DGR8. 
 U3 C/D snoRNA-derived miRNAs are also found in the cytoplasm. 
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SCRUTINIZING MIRNAS REPRESSION ACTIVITY AT THE SINGLE CELL LEVEL 
 
miRNAs studies have increased in resolution thank to NGS, computational analysis, in vitro 
and kinetics studies (See 1.1.2.2 Introduction). This understanding allows system biologist to 
apply modeling and explain the intricated miRNA networks. 
Despite these advances, the field lack of functional analysis with higher resolution. For 
instance, the broadly used luciferase assays give a small hint on miRNAs functionality because 
it provides an average functionality for the whole miRNA population. Moreover, luciferase-
based assays have an expression-threshold that yields discernable differences for high 
expressed miRNAs, leaving out the vast majority expressed miRNAs and disregarding the fine-
tuning action of miRNAs. 
In the first section, I described that C/D-miRNAs concentration is low, making luciferase assay 
or quantifying RNA targets (mRNA) unsuitable. To test C/D-miRNAs endogenous activity, I 
decided to design my functional standard.  
I reasoned that if a dual reporter sensor -like the luciferase, could be quantified at single cell 
level, It should increase resolution allowing to test C/D-miRNAs activity. I thought that FACS 
analysis would allow individual cells and specific fluorescence analysis. Thus, I interchanged 
the luciferase genes for fluorescent proteins. 
I held that the new technique required a systematic development to give reliable results; 
therefore I generated the constructs and proofed its concept; evaluated and validated it for 
canonical miRNAs, and apply it for C/D miRNAs. Figure 25 describes each performed step. 
First I generated fluorescent plasmid and compared it with luciferase, and then I set up an R 
environment to use FACS outputs. Using a mathematical model I predicted different miRNA 
behaviors and I evaluated them with a siRNA as control of active RISC because siRNA use the 
same functional pathway, and finally, I validated the model for miRNA using the expression 
from Ion-Torrent profiles.  
 
 
 53 
 
Figure 25. Advanced dual fluorescent reporter for the comprehensive, high-resolution 
analysis of miRNA based regulation.  
Generation, evaluation, and validation of a fluorescent reporter for miRNAs functionality.  
Outline describes three steps: 1. Biologics (A) Generation of constructs with distinctive 
fluorescent proteins and (B) data acquisition and analytical processing, - analytical function 
generation. 2. Data Analysis: (C) Mathematical description of miRNAs regulation regarding 
Kon, Koff, and miRNA concentration, (D-E) in-vivo predictions test with non-human targeted 
siRNA. 3. Validation: (F) Expression levels from small RNA NGS libraries and (G) analytical 
function test for endogenous miRNAs using the fluorescent reporter, (H) quantitative analysis 
of miRNA regulation in vivo.   
 
2.1.25 GENERATION OF DUAL FLUORESCENCE PLASMIDS: PROOF OF PRINCIPLE.  
 
2.1.25.1 Whole population analysis and comparison with luciferase based assays  
The simple principle of the system is to use a single plasmid with two fluorescent proteins; it 
uses one as a sensor and one as a reference, both will be transcribed, while the ribosome 
translates the patron, the miRNA machinery inhibits the translation. In the end, the difference 
sensor-reference would serve as miRNA functional quantification (Figure 26). 
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Figure 26 Untranslated trans assay: 
theorical principle 
 The reporter system is based on two 
fluorescent proteins with different 
excitation and emission spectrum; one is 
used as transfection reference and the 
other as miRNA sensor. Upon transfection 
mRNAs is transcribed, translated and the 
relation between the two reporters 
describes the activity of endogenous 
miRNAs. 
 
This principle is analogous to the F/R from luciferase assays, so I took its backbone and 
replaced it with different fluorescent proteins, I generated three constructs with CFP/GFP, 
CFP/YFP, and RFP/GFP combination. Table 1 summarizes the generation strategy. 
As proof of principle, a transfected the plasmids, analyzed them by microscopy and flow 
cytometry, and compared it with the luciferase assays. For the sensor proteins, I used two psi-
Check constructs (miRNAs miR-23a-3p and miR-27a-3p, produced by Henrike Höke), and I 
introduced the exact sequences on CFP or RFP.  
 The microscopy results showed that the miRNA insertion on RFP reduced its expression 
comparable to non-cognate insert, while GFP expression is similar on the three of them. 
Relative intensities were calculated using the ImageJ software, and the ratio of both proteins 
calculated ( Supplementary Figure 8). Boxplots show that the miRNA insertions have a lower 
RFP/GFP ratio than the non-cognate control.  
FACS analysis of the CFP-YFP construct show similar pattern, the scatter plot indicate that the 
CFP and YFP are proportional in all the constructs, while the non-cognate control displays a 
linear trend, the miRNA samples resembles a quadratic equation (Figure 27).  
Density plots of CFP/ YFP ratio show a normal distribution, while the lowest average was for 
miR-27a-3p, it has the higher standard deviation (Figure 22 B); furthermore, the whole 
population analysis for fluorescence displayed similar trend to the luciferase R/F assays.   
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Figure 27 Dual Fluorescence Reporter characterized in-vivo miRNA activity 
 The reporter uses two independent fluorescent proteins expressed individually from two 
different promoters. CFP contained a target region for miRNAs within the 3’ UTR, while YFP is 
unaffected. Human Hek293 cells were transfected with three constructs (miR-23a-3p, miR-27a-
3p and Non-cognate as control) and evaluated 72 h after. (A) FACS Scatter plots measurements. 
(B) Bulk quantitative analysis using CFP/YFP ratios, as density and boxplot,  were calculated using 
custom R scripts. (E) Standard luciferase assays from Hek293, psi-check constructs were 
transfected with miRNA 23a-3p and miRNA 27a-3p targets located within the 3’UTR of Renilla 
luciferase and evaluated after 72h, bar plots show the ratio between Renilla and Firefly 
luciferase 4*. 
2.1.26 SINGLE CELL LEVEL ANALYSIS: MOLECULAR TITRATION MODEL FOR MIRNA INDUCED 
POSTRANSCRIPTIONAL REGULATION 
 
2.1.26.1 Mathematical models for sRNA regulation 
                                                          
4
 *Data analysis performed together with Michael Mitter during his Lab Rotation Molecular Biology 
program under Lemus Supervision). 
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Looking at the scatter plots from the fluorescent reporters, I noticed three characteristics: 
 The transient transfection creates a broad range of intensities for YFP and CFP. 
 The non-cognate control shows a linear trend, where CFP increases similarly to 
YFP. 
 miRNA-target insertion kept the both proteins proportional, but I recognized a 
deviation from linearity. 
I thought that the FACS outputs could be understood using mathematical expressions. 
Initially, I tried with a simple nonlinear fit, but parameters outputs didn't give any intuitive 
meaning (data not shown). For that reason, I looked for distinct mathematical models and 
found that regulatory networks and molecular titration models offered a suitable alternative 
to interpret raw FACS data.   
Molecular titration in regulatory networks 117 offered a good alternative, titration occurs 
when an active molecule (X) is sequestered into a non-active complex by a titrating molecule 
(Y). When  Y  concentration is larger than the Kd of the complex, it works as a buffer for the 
accumulation of X, so when X equals Y, overcomes the Y buffer activity and increases rapidly 
creating a threshold response.  
Briefly, the threshold response means (analogous to a buffer in pH tittering)  that at a 
concentration below the threshold X changes are buffered (sequestered) by Y, and miRNAs 
certainly, behave as sequesters of mRNAs. I decided to implement this molecular titration 
into my reporter system and found that similar system has been used to define switch-like 
and tune activity for miRNAs and sRNA37,44,117,118. 
For the sake of simplicity, I will describe in this section a simplified model based on bacterial 
sRNA regulation and simulate data, explaining the concept of threshold-linear behavior.  Then 
I will describe and simulate a molecular titration model for miRNAs, defining structured 
predictions. In the next section, I will experimentally test these predictions and validate them 
using endogenous miRNAs.   
To keep coherence I will follow the structure of scientific papers using mathematical models, 
for it, I will describe in results the model, the set of ODE and the results of simulations. 
2.1.26.1.1 sRNA regulation in Bacteria: Repression Threshold mathematical definition.  
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I wanted to apply mathematics and apply it to my single cell analysis; not as system biology 
study but a tool to functionally characterize endogenous miRNAs, for its simplicity and to 
define threshold-linear behavior I will explain the model from 118 (Figure 28).  
The mathematical model defines the following sets of ODE: 
Equation 1 
  𝑑𝑟
𝑑𝑡
= 𝐹𝑟 − 𝑑𝑟𝑟 − 𝑘𝑚𝑟 
Equation 2 
  𝑑𝑚
𝑑𝑡
= 𝐹𝑚 − 𝑑𝑚𝑚 − 𝑘𝑚𝑟 
 Equation 3 
𝑚 =
1
2𝑑𝑚
(𝐹𝑚 − 𝐹𝑟 −  + √(𝐹𝑚 − 𝐹𝑟 − )2 + 4𝐹𝑚)       𝑤ℎ𝑒𝑟𝑒   = 𝑑𝑟𝑑𝑚/𝑘 
 
Figure 28 Small RNAs gene regulation: the simple picture. 
Simplify model of sRNA regulation. The cell transcribes mRNAs and sRNAs at Fm and Fr rates 
respectively; free mRNA could be translated, sRNA repressed or decayed at dm rate, the 
relation between Fr and Fm depends on the binding constant between sRNA and mRNA,  
showed here as K. 
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Equation 1 Describes the change in time for of the mRNA; it is transcribed at a rate Fm and 
degraded at dm, while the second equation defines the expression of the repressor sRNA, 
with a similar set of rates Fr and Dr. The complex sRNA-mRNA has a second order kinetic 
constant K (Figure 28). 
Solving equations 1 and 2 for steady state, drops Equation 3. Using mathematical simulations 
for several transcription rate Fr (M/m) and gene expression m (nM of protein), assuming that 
all the mRNA is translated. We can observe two scenarios in the sRNA induced "buffering" 
(Figure 29. When the mRNA concentration is higher than sRNA (Fr<Fm)(Figure 29 A) we get a 
linear increase of protein (Figure 29 C); whereas,  in the case (Fr>Fm), no protein is detected 
(Figure 29 B and C). This behavior is what I will call repression-threshold. 
 
 
 
Figure 29 Threshold linear response of a target mRNA  
Small-RNA's regulation idealized model describes the relationship between the 
transcription rate (Fm) and protein concentration through an sRNA response function. (A) 
If Fr (sRNA) is lower than Fm (mRNA), the free mRNA is translated. While, (B) If Fr is higher 
than Fm, the mRNA is degraded reducing protein yield. (C) Simulation plot depicts mRNA 
transcription rate (M/min) versus gene expression (nM). If the sRNA is higher than the 
mRNA, it represses protein expression, while if the mRNA concentration is over the sRNAs, 
the relation between the transcription rate and the gene expression will be proportional.  
The start of linear behavior defines a repression threshold, at idealized conditions is equal 
to the sRNA concentration (Black line), while in a biological system, it has a gradual onset 
of linearity and the association constant (K) governs the curve shape (green line). 
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In idealized conditions all the sRNA degrades the mRNA, the linear function intercept will be 
equal to the sRNA concentration and the repression-threshold. However,  a biological system 
is not ideal, so the linearity on is gradually governed by K.  
2.1.26.2 Molecular titration model for miRNAs posttranscriptional regulation 
After defining repression threshold and describing the threshold-linear behavior with a simple 
sRNA model, I used a more complex set of ODE for miRNAs, described by Mukherji 44;  the 
model is depicted in Figure 30 
 
The model describes the titration of miRNAs of mRNA, the complex formation r*, depends on 
the Kon and Koff of the complex, that depends on the miRNA complementarity and targets in 
the mRNA. The following equations described the change of the mRNA free to translate and 
the miRNA complex.  
Equation 4 
  𝑑𝑟
𝑑𝑡
= 𝑘𝑟 − 𝐾𝑜𝑛𝑟[𝑚𝑖𝑅𝑁𝐴] + 𝐾𝑜𝑓𝑓𝑟
∗ − 𝛾𝑅𝑟 
Equation 5  
 
Figure 30. Titration model of miRNAs induced regulation  
The model for miRNA's regulation describes the free mRNAs available for translation. In the 
absence of miRNA, the cell transcribes and degrades mRNA at rates Kr and γr respectively. In 
presences of miRNAs, the free mRNA available for translation depends on the miRNA-mRNA 
(r*) complex,  its  formation   depends  on  on-rate  (Kon)   andand miRNA concentration. Then 
two mutually exclusive paths occur. Either it induces mRNA degradation (at γr* rate), or 
disassembles into its components (at Koff rate). The first order equations that describe the 
model are in the text. 
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  𝒅𝒓
𝒅𝒕
= 𝑲𝒐𝒏𝒓[𝒎𝒊𝑹𝑵𝑨] − 𝑲𝒐𝒇𝒇𝒓
∗ − 𝜸𝑹∗𝒓
∗ 
In this context, total miRNA concentration is considered as the free miRNAs plus the miRNAs 
included in the complex (r*): 
Equation 6 
[𝑚𝑖𝑅𝑁𝐴]𝑇 = [𝑚𝑖𝑅𝑁𝐴] + 𝑟
∗ 
 
It is assumed that no translation is happening from miRNA bounded RNA, and only from the 
free RNA (r). And solving for the steady-state levels of r as before 44:  
Equation 7 
𝑟 =
1
2
(𝑟0 − 𝜆 − 𝜃 + √(𝑟 − 𝜆 − 𝜃)2 + 4𝜆𝑟0) 
Where =  
𝑟𝑜=
𝐾𝑅
𝛾𝑅
                    𝜆 =
𝛾𝑅∗ + 𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
           𝜃 =
𝛾𝑅∗
𝛾𝑅
 [𝑚𝑖𝑅𝑁𝐴]𝑡𝑜𝑡𝑎𝑙 
So, for the sake of simplicity, I will use the term miRNA binding for 𝜆, even though it could 
have more sense to use as synonym of Kd. However, lambda has more elements and probably 
can confuse the educated if I use 𝜆 as Kd.  
2.1.26.3 Molecular titration model simulations  
Since the threshold-repression model matches qualitatively the fluorescent reporter scatter 
plots (Figure 27), I thought to create a set of predictions to test how well it describes the in 
vivo FACS outputs. 
I simulated values of r (mRNA free for translation) using the equation (Equation 7), with 
increasing values of Ro (mRNA without miRNA regulation), and varying miRNA concentration 
(θ) and binding (λ (~1/Kon)). 
Results of two scenarios resemble well the scatter plots results when miRNA is kept constant,  
1/λ increasing values introduce a sharp in the repression threshold, defining that the binding 
of the miRNAs λ controls the threshold-linear onset.  And the miRNA levels control the 
regulation intensity, so when threshold-linear onset is determined, the increasing miRNA 
concentration θ will shift the curve (Figure 31). 
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Admitting that the analogies have limits and the weakness, we can say that λ is like the slope 
and θ the intercept in linear regression, however from the simulation it is clear how each 
parameter influences the curve shape. 
A 
 
B 
 
Figure 31 Numerical simulations describe miRNA-induced thresholding    
Steady state solution for free mRNA (r) as a function of initial mRNA transcription (r0). The 
solutions yield to lumped parameters (Equation 4): λ inverse proportional to Kon, and θ 
equivalent to the miRNAs concentration. Numerical simulation of steady state solutions for 
(A) several λ (1/Kon) and constant θ (miRNAs), and (B) for increasing amounts of miRNA (θ) 
and constant λ (1/Kon)4*. 
2.1.26.4 Molecular titration model test experiments 
I wanted to simplify the output from the raw data from single cells, therefore I generated a 
processing data and visualization tool in R, and called the result analytical function (Figure 32)  
The R environment creates the analytical function by transforming the raw data into a simple 
line, for that, it divides the YFP positive cells in small bins of 0.05, and calculates the 
descriptive statistics per bin. Then it uses this value to create a curve. Briefly, each dot in the 
analytical function is the average value CFP value for a range of 0.05. The transfection 
standardization and negative controls showed that 72 h and just one microgram yield reliable 
analytical functions (Supplementary Figure 9 and Supplementary Figure 10). 
 
                                                          
4* Simulation can be reproduced at https://medicalrnabiology.shinyapps.io/pUTApp/ 
Constant"θ" Constant"λ"
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Figure 32 Dual fluorescent reporter analytical flow cytometry: Function generation from 
single cell measurements   
Analytical processing of transfected cells starts selecting YFP expressing cells(Grey dots), only 
events greater than two Standard deviations from the negative control (non-transfected cells) 
are considered. The function (Green dots) represents the mean from binned intensities -1 to 
8 at 0.05 intervals. As an example, Hek293 cells were transfected with two reporter plasmids, 
and FACS analyzed after 72 h. Analytical functions depicted for  (A) Non cognate and (B) miR-
27-3p targeted reporters.  
2.1.26.4.1 Lambda and theta experiments with GL-2 
In the previous section, I described that the parameters θ and λ influences the shape of 
miRNA titration curves; θ represents miRNA concentration and shifts the titration line down, 
while modulating λ (1/Kon) sharps the threshold-linear onset, so that lower values give a 
distinctive transition to linearity.  
I reasoned that if the model applies to the fluorescent system it should be tested it 
empirically, so using a siRNA (GL-2 that targets luciferase gene) at increasing concentration I 
tested whether siRNA increments behaves as the predictions for θ. 
To inquire λ predictions, I modified the target sequence in CFP 3'-UTR, to increase the miRNA-
mRNA complex formation I inserted one and three perfect copies of GL-2 target sequences, 
and to reduce miRNA-mRNA interaction, I added incomplete GL-2 sequences and test it with 
siRNA transfection. 
Co-transfection experiments (siRNA-fluorescent sensor) show that upon siRNA increasing 
concentrations the analytical functions shift down for the GL-2 targeted CFP (Figure 33 B and 
Figure 34 B), without changes for the non-targeted control (Figure 33 A and Figure 34 A). I 
observed similar behavior for three and incomplete sequence (Figure 34)  
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Figure 33 Exogenous expression of siRNA shift analytical functions in vivo. 
The miRNA-regulation model describes θ as proportional to the total miRNA levels and the 
numerical simulations (Figure 31) show function shift upon increasing θ values. Increasing 
concentrations of a non-cognate siRNA (GL-2 Control) were co-transfected in Hek293 with 
two dual fluorescent reporters, (A) negative control and (B) GL-2 targeted, analytical-
functions derived from FCAS were produced after 72 h post transfection. Scatter plots show 
representative data from at least three independent experiments (Representative of at least 
3 experiments).  
Remarkably, modulating the target sharps the analytical function, the co-transfection of 
modified GL-2 sites (bulged) shows a small shift in the analytical curve, and three copies have 
a clearer threshold-linear onset than one or bulged sensors. 
Briefly, I considered that I could not deny that the molecular titration model can be used for 
the FACS analysis; so, we decided to call the complete analysis  (FACS and R environment), as 
analytical flow cytometry for miRNA function in vivo. Contemporary to this thesis Bartel and 
Stoffel used also the term analytical flow cytometry 119. 
2.1.26.5 Insight on miRNAs posttranscriptional regulation   
2.1.26.5.1 siRNA experiments yield three functional groups. 
The analytical curves from GL-2 experiments resemble the titration model predictions for 
increasing miRNA concentration and binding capability. So, I decided to apply it to miRNAs, 
but with a systematic perspective derived from the model.  
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Since expression is the often-analyzed parameter from miRNAs and defines the "repression" 
ability, I observed all the analytical results and established three categorical variables. To 
clarify miRNA functionality, applying the effects of θ and λ.   
 
Figure 34. Increasing reporter binding sites sharps siRNA induced threshold in vivo.   
The miRNA-regulation model describes λ  as inversely proportional to Kon, and numerical 
simulations (Figure 24) show threshold sharpening after decreasing λ values. To artificially 
increased or decreased binding events, several non-cognate (Gl2) targeted sites were 
inserted into the dual fluorescent reporter. Constructs were co-transfected with increasing 
siRNA-Gl-2 concentrations and analyzed by FACS; Scatter plots depict An analytical functions 
for (A) Negative control (B) Bulged Gl-2  (18 complementary plus three unpaired bases, and 
for (C) single and  (D) three perfect GL-2 complementarity copies. (Representative of at least 
3 experiments). 
These categories (Qualitative variables), which are defined by the curve shape and position, 
are high, mid and low functional. To simplify the description (Experimental and in silico), I will 
describe the curve shape-position, parameters estimation, and simulation, and conclude with 
an integrated definition for the groups. 
These categories (Qualitative variables), which are defined by the curve shape and position, 
are high, mid and low functional. To simplify the description (experimental and in silico), I will 
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describe the curve shape-position, the parameters estimation, and conclude with an 
integrated definition for the groups using an empirically based simulation.  
For high siRNA concentration (blue), all "λs" reduce CFP expression being three and one 
closer in their repression curve. For a mid siRNA concentration (red) one and bulged copies 
repress CFP similarly, and for small siRNA concentration (green) the three positions are closer 
to the controls (Figure 35).  
 
Figure 35. In vivo-derived analytical functions describe three functional groups  
In vivo analytical functions from Gl-2 siRNA experiments define three categorical variables 
based on siRNA concentration and binding sites: low, mid and high functional.  The scatter 
plots depict three siRNA concentrations -(A) 20 nM (B) 1.5 nM and (C) 0.5 nM) and three 
GL-2 targeted constructs -Bulged, one and three copies. To define θ and λ ranges we fitted 
the analytical functions from GL-2 (siRNA) using non-linear regression, (D) numeric 
simulations from in vivo derived parameters; the plot shows the steady state solutions for 
nine combinations of θ (Colors) and 1/λ (lines). 
For the curve shape, high siRNA concentrations depict a threshold-linear onset and keep it for 
three copies at 1.5 nM of siRNA, while no thresholds appear at low siRNA concentration 
(Figure 35 A-C). 
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Using the intensity ranges for YFP, I used nonlinear least squares to estimate θ and λ using the 
analytical cytometry data and defined the limit, which can be used for estimation in 
experimental data, to simulate curves based on the actual experimental window.  
The simulation shows a trend that justifies the categorical classification (Figure 35 D), showing 
that the bulged-siRNAs functions have no observable threshold and depict a lateral shifting. 
Perfect one and three copies exhibit threshold differences, while for the high functional group 
the curves are nonlinear, the middle group curves display an intermediate shape. 
In model terminology, the low functional miRNAs own a small mRNA repression within 
several 1/λ at low θ, showing no threshold and shifting the intercept of the linear behavior.  
For the high and mid functional groups, the curve shape depends on 1/λ and θ cooperation. 
Meaning that high values for 1/λ drag medium-expressed miRNAs into the high functional 
group (blue), while, highly expressed and low 1/λ, bring the function close to the mid (red) 
group (Figure 35 D). 
2.1.26.5.2 Insight on the miRNA titration model  
Till now, I described and simulated a miRNAs molecular titration model, I tested its prediction 
experimentally and proposed three functional groups and re-ran the simulation with 
estimated factors. I wanted to apply this classification and modeling to endogenous miRNAs 
to analyze functionality low expressed miRNAs, but also to distinguish in detail responses of 
high expressed miRNAs.  
Furthermore, to define and understand any behavior from endogenous miRNA, I run several 
simulations to clarify distinct scenarios, creating a deeper understandiNG OF THE MIRNA 
TITRATION MODEL, using first situations with different Kon and Koff, changing the concentration 
afterward.    
The numeric simulation reveals the Kon influence upon the threshold on set (Figure 36 A - B). 
For Kon equal or lower than the Koff, the curves lose an identifiable thresholding (Figure 36 C 
- D), supporting that the miRNA-mRNA complex formation determines the threshold-linear 
transition.  
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Figure 36 .Threshold transition to linearity depend on miRNA-mRNA complex formation  
Plots depict numeric simulations performed using the in vivo derived λ range, four 
scenarios defined by Kon and its relation with Koff and y*r. In A the plot shows the 
threshold transition at high Kon values, and B depicts a situation with an ideal miRNA, 
where the Kon extremely high, and the dissociation (Koff) is close to zero.  C describes the 
function shape in conditions where Kon is similar to Koff and D depicts the function form 
when Kon is lower than Koff.  Simulation can be reproduced at 
https://medicalrnabiology.shinyapps.io/pUTApp/ 
The increasing concentrations (θ) show that high Kon sets the thresholds closer to the miRNA 
expression, indicating that just in ideal conditions the expression equals repression 
(threshold) (Figure 37 A-B), but in biological systems, the threshold-linear onset behaves 
dynamically.  
Increasing miRNA concentrations of Kon ≈ Koff show experimentally undetectable YFP  
threshold-linear −Compare YFP axis of simulations and analytical functions. Finally, the linear 
onset for Kon<Koff happens at small YFP intensities, anticipating that empirically the 
analytical cytometry would just depict the linear section of the threshold-linear behavior.    
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Figure 37 Threshold limit is controlled by miRNA expression. 
Plots depict numeric simulations performed using the in vivo derived λ and θ range, four 
scenarios defined by Kon and its relation with Koff and y*r, all the graphs have four θ values. In A 
the plot shows smooth threshold transition for high Kon values, while B depicts ideal miRNA, 
where the Kon is extremely high, and the change to linearity is abrupt. C describes the function 
shape in conditions where Kon is similar to Koff and presents a mild threshold transition. Finally, 
D depicts the function form when Kon is lower than Koff; the threshold is smooth and at low YFP 
values. Simulation can be reproduced at https://medicalrnabiology.shinyapps.io/pUTApp/ 
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2.1.27 MEASURING ENDOGENOUS MIRNA ACTIVITY AT THE SINGLE CELL LEVEL 
2.1.27.1 Functional Test using analytical flow cytometry 
I demonstrated that molecular titration simplifies and estimates factors out of fluorescent 
miRNA sensor; I described three categorical variables, which represent miRNA functionality 
(low, mid and high). Next, I applied it to selected miRNAs to examine endogenous miRNAs 
activity; using the small RNA Ion- Torrent. I chose several miRNA candidates within a broad 
expression range and tested them using analytical flow cytometry (Figure 38).  
 
Initially, I tested candidates from all the quartiles (transformed reads) evaluating outliers and 
average miRNAs; noticeably I found (as the model predicted) an inconsistency between 
 
Figure 38 miRNA Analytical functions uncouple expression from functionality 
Perfect complementary sequences for thirty selected miRNAs (with distinct expression 
patterns Figure 8) were inserted into CFP 3′UTR, transfected into Hek293 and evaluated after 
72 h. Scatter plots depict analytical functions for three groups, according to the shape of 
their curve. (B) High functional that have a threshold up to high YFP intensities, (C) mid with 
a threshold at moderate YFP intensities, and (D) low functional with no observable threshold 
(Compare with Figure 35). (E) Functional groups were used as ordinal variables to compare 
the mean normalized counts between groups (P < 0.01 Kruskal-Wallis test, Dunns multiple 
comparisons test * < 0.05). 
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expression (relative miRNA concentration) and the function shape. So I increased the 
measurements evaluating 30 different miRNAs.  
The miRNA's analytical curves parallel the categorical classification derived from siRNA 
experiments; consequently, high functional miRNAs display a clear threshold, mid produce a 
gradual unsharp linearity onset; and the last group (low) exhibits a little shift resembling 
linearity.  
 Comparing the expression within each class (As anticipated by the titration model Figure 35), 
I observed no discrepancy between adjacent groups and significant difference between high 
and low functional groups, showing that expression begets no through repression for 
endogenous miRNAs. To explain it, I used nonlinear least squares and estimated θ and λ; to 
do so, I reduced the bin size (0.01) to increase data points securing accuracy in the estimates, 
then I compared the estimated factor with expression (Ion-Torrent profiles) and functionality 
(high, low and mid). 
Calculated λ discriminates high and mid from low functional miRNAs, while θs is proportional 
to Ion-Torrent expression profiles  (Figure 38 and Figure 39), indicating that differences 
between mid and high functional miRNAs, could be influenced by separate factors exceeding 
miRNA expression.  
 
Figure 39 miRNA titration model integrates expression and binding in vivo 
Produced analytical functions were fitted (non-linear least squares regression), to estimate λ 
and θ.  (A) Calculated 1/λ (~Kon) plotted vs. different functional groups (P < 0.05 Kruskal-
Wallis test, * < 0.05 ** < 0.01). (B) Expression as mean normalized counts (Figure 8) vs. 
calculated θ (~miRNA). 
I reasoned that factors like ratio miRNA-targets or miRNAs subcellular location could reveal 
how expression deviates from functionality. Using subcellular RNA profiling of Hela cells  
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(3.1.1.3), and after observing that the analytical cytometry yield the same shapes and groups 
for HeLa (Supplementary Figure 11), I examined whether miRNA subcellular location 
influences the FACS functional outputs (  Figure 40). 
 
A 
 
B 
 
C 
 
  Figure 40 miRNAs Subcellular localization influences their analytical output 
Four individual miRNAs were chosen according to their cellular expression, 3 miRNAs on 
low and mid functional groups with expression higher than the high functional median 
(miR-103a-3p, miR-18a-5p, miR-24-3p) and one high functional miRNA lower than the mid 
functional median of normalized cellular read counts. (D) Analytical transfer functions (E) 
Bar plots for cellular compartments of small RNA libraries and (F) Cytoplasmic/Nuclear 
ratio for selected candidates. 
   Transfection figure A performed together with Maximilian Arlt duting his Bachelor thesis under Lemus Supervision). 
I selected two outliers: the first (miR-103a-3p) from the low functional miRNAs, which is over 
the percentile 75% of its cluster, and the second (let-7c-5p) from the lower expressed inside 
high functional miRNAs; at the same time, I assessed the intersection between mid-high 
miRNAs selecting miR-18a-5p and miR-24-3p. 
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The combination of analytical cytometry and subcellular profiling indicate that the miR-103-
3p (highly expressed but limited functionality) holds a small cytoplasmic-nuclear ratio. 
Additionally, the analysis shows that miR-18a-5p and miR-24-3p own small cytoplasmic-
nuclear proportions. Finally, the fourth candidate let-7c that performs as a high functional 
miRNA but mildy expressed is located solely in the cytoplasm. 
In summary, these findings underline that analytical flow cytometry applies to other cells 
types, it can define alternative hypothesis based on its outputs, like that miRNAs subcellular 
location determines miRISC functionality, suggesting that small RNA profiles without 
systematic and detailed functional outputs could be misleading 
2.1.27.2 Threshold modulation of endogenous miRNAs 
I showed that the miRNA titration model, together with the analytical outputs, resolves 
better the repression of endogenous miRNA, defining precise curves and allowing the analysis 
of new hypothesis when integrated with expression profiles. 
As with C/D-miRNA experiments, I wanted to refute that endogenous miRNA follow the same 
trend as the exogenous siRNAs experiments (2.1.26.4), in other words, to inquire whether θ  
and λ parameters apply to endogenous miRNAs. I used several target sequences for miR-27a-
3p, introducing different copies (1 and 4 bulged -incomplete miRNA target and 1 to 3 perfect 
complementary) into the fluorescent sensor and examining them in Hek293 cells; to estimate 
parameters (θ  and λ) using equation 7. 
Adjusting miR-27a-3p target in the reporter increases the threshold sharpness (Figure 41 A), 
linking it to 1/λ values, keeping θ estimates without changes for all copies (Figure 41 B - C), 
this trend also applies to other miRNAs (Figure 41 D-E). 
To examine θ without the external use of miRNAs (exogenous expression of miRNA), I 
thought to change the active miRNA concentration inside the cell, using siRNAs (with and w/o 
target) to out-compete endogenous miRNAs shifting up the analytical function. In simpler 
terms, overloading the cells with sRNAs shall reduce the miRNAs working concentration. 
Remarkably, co-transfection with siRNA shifted the analytical curve for three selected miRNA; 
reducing its effectivel miRNA amount, independently of siRNA target (GL-2 and LMNA) and 
working for all the groups (low, mid and high). 
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Remarkably, co-transfection with siRNA shifted the analytical curve for three selected miRNA; 
reducing its effectivel miRNA amount, independently of siRNA target (GL-2 and LMNA) and 
working for all the groups (low, mid and high). 
Considering that human miRNA targets are not entirely complementary and defining whether 
the analytical cytometry is also valid for endogenous targets. I inserted the seed, seed plus 
motif and the complete targets for miR-92a (derived from CLASH analysis), to point out that 
the system is useful for endogenous 3' UTRs. For open-source sharing, the plasmids are 
located at Addgene. 
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Figure 41. Threshold sharpening for endogenous miRNAs 
To sharp threshold of miR-27a-3p several target sites, bulged and perfect, were inserted at 
3′UTR of CFP, Hek293 cells were transfected and analyzed by FACS after 72 h. (A) 
Analytical functions for perfect binding sites (“P”- P1-P3) with one, two and three copies, 
and one and four copies of a bulged site (“B” -B1 & B4) -three unmatched bases-. 
Analytical functions were fitted using non-linear least squares to estimate θ and λ values.  
Plots show miRNAs copy number vs. (B) estimated θ (~miRNA) and (C) 1/λ (~Kon); values 
for bulged were arbitrary set to 0.2. Three miRNA candidates for each functional group 
were selected and tested to sharp their threshold; plots show (D) low, (E) mid and (F) high 
functionality functions for one and three perfect copies.   
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Figure 42. Threshold shift by outcompeting miRNA with siRNA in vivo. 
To modify θ (~miRNA), but without changing endogenous miRNA expression, siRNAs were 
co-transfected with the reporters to outcompete miRNA, reducing the functional miRNA 
concentration. Three different miRNAs were selected, co-transfected with two different 
siRNA and evaluated after 72 h. Plots depict (A) low, (B) mid and (C) high functional 
miRNAs.   
ENDOGENOUS ACTIVITY OF C/D SNORNA-DERIVED MIRNAS 
 
Summarily I pointed that C/D snoRNA locus can produce RNA in the range of miRNAs, they're 
located mainly in the nucleus, and low expressed compared to canonical miRNAs. 
Furthermore,  they are undetectable in Argonaute and Dicer RNA pull-downs but interact 
with DGCR8, suggesting that C/D miRNAs are not working as classic miRNAs.  
However, 5' domain of the C/D snoRNAs U3 produces RNAs around 21 nt, it is found in the 
cytoplasm and interacts with all the miRNPs, but it is scarce expressed. Since no technique 
can quantify endogenous miRNA function in-vivo at high resolution, and the C/D-miRNAs are 
in few number, I developed an analytical assay that characterize low expressed miRNAs 
activity in vivo.  
 
2.1.28 ANALYTICAL FLOW CYTOMETRY OF C/D SNORNA-DERIVED MIRNAS THRESHOLD 
MODULATION.  
 
To perform another disproval attempt for the C/D-miRNA, I inserted the complete 
complementary sequences for the C/D miRNA (U78, U44, and U3) in the fluorescent reporter.  
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As a control, I used the H/ACA miRNA ACA45 and an extremely low expressed miRNA-451a  
(Not found in Ion Torrent, and few in the GEO data sets).   
The miRNA titration model predicts for low expressed miRNAs that increasing 1/λ shift 
minimally the analytical curve, while the line displacement is greater for mid and high 
functional miRNAs respectively (Figure 43A). Experimentally miR451-3p, ACA45, and U78 
functions show a small shift, while U44 completely overlap the controls (Figure 43 B and C). 
For U3 derived miRNAs, located at 5' and 3' domains Figure 44  A, the analytical functions 
depict a slight displacement for the U3 (45-64) and U3 (195-214) (Figure 44 B and D), while U3 
(75-94) keeps its lines overlying the control. 
From the miRNA titration model and the analytical flow cytometry, I defined two steps to 
modulate endogenous miRNA activity in vivo (Figure 41 and Figure 42): improving binding by 
increasing target copiesin the sensor (CFP 3' UTR), and out-competing miRNAs by an external 
siRNA overload. 
2.1.29 ANALYTICAL FLOW CYTOMETRY OF C/D SNORNAS: OUTCOMPETING MIRNAS.  
 
From analytical flow cytometry, I established two steps, which use the titration model, to 
examine miRNAs activity in vivo by increasing binding (Figure 44) and overloading the cells 
with siRNAs. 
The out-competing experiments for miRNAs show a shift again up of miRNAs curves, in these 
experiments, I used miR-451-3p as lowly expressed miRNA, miR 221-3p as mid functional and 
miR-92a high functional miRNA (Figure 45 A - D and Section 2.1.26.5). Overloading the cells 
with siRNAs upshift the analytical curves for U3 (45-64) and ACA45 (Figure 45 E and H), while 
it does not affect U3 (195-214) and U78 (Figure 45 F and G).  
Consequently, the analytical cytometry outlook determines that all the selected C/D-miRNAs 
contradict the miRNA model, except for the U3 5' domain located miRNA and H/ACA miRNA 
ACA45, suggesting that the intronic snoRNA yield no canonical miRNAs. 
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Figure 43. snoRNA-derived miRNAs analytical resemble low functional miRNAs.  
Dual fluorescent constructs containing full complementary sequences of snoRNA-derived miRNA 
were transfected in Hek293 cells and evaluated after 72 h. (A) Depict model prediction for three 
miRNAs with low, mid and high functionality to contrast curve shift upon 1/λ increments (full vs. 
dashed line).  Scatter plots show analytical functions for (B) Positive control   miR-451a, H/ACA 
snoRNA-derived miRNA (C) ACA45, (D) U44, and (E) U78. 
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Figure 44. U3 derived miRNA function resembles low functional miRNAs. 
Dual fluorescent constructs containing full complementary sequences of snoRNA-derived 
miRNA were transfected in Hek293 cells and evaluated after 72 h. (A) The cartoon depicts U3 
secondary structure, in bold shows functional elements and it highlights the small-RNA found 
in NGS libraries. Full complementary regions inserted at the CFP 3'UTR  were transfected in 
Hek293 cells and evaluated 72 h after. Scatter plots show analytical functions for  (B) U3 (45-
63), (C) U3 (74-94) and U3 (195-214), colors are paired between the cartoon and the scatter 
plots.   
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Figure 45. Outcompeting miRNA-derived snoRNA shift the ACA45 and 5’-U3 domain 
analytical function. 
Constructs containing full complementary sequences of snoRNA-derived miRNA and siRNA 
were co-transfected in Hek293 and evaluated after 72 h. (A) Model predictions for three 
different functional miRNAs and analytical functions for (B)High, (C) mid and (D) low functional 
RNA, red dots depict the outcompeting siRNA resultant function. snoRNA-derived miRNA 
analytical curves for (E) H/ACA box ACA45,  (F) C/D snoRNA U78 and (G) 3 ' and (H) 5' domains 
U3 derived miRNAs. Simulation can be reproduced at  https://medicalrnabiology.shinyapps.io/pUTApp/. 
2.1.30 CLASH CHIMERAS FOR U3  5’ DOMAIN DERIVED MIRNAS. 
 
As last attempt to disprove that U3 5' domain works as a miRNA, I used the Hyb pipeline in 
CLASH data sets and subset specifically for snoRNA-mRNA chimeras, because this technique 
recovers miRNA targets accurately, U3 5' domain shall show hybrid formation as canonical 
miRNAs.  
Calling chimeras for snoRNA in CLASH data30,91, recover three chimeric reads for U3 (45-64), 
and their base pairing resemble non-canonical miRNA motif (Figure 46). 
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Figure 46. 5’-U3 domain derived miRNA’s chimeras identify mRNA targets 
Ago1 raw data from crosslinking and analysis of hybrids (CLASH), was analyzed with Hyb 
pipeline subsetting for snoRNA. (A) Table summarized called chimeras from U3 5' domain, 
and dot-brackets notation from identified chimeras. (B) Cartoons depict secondary structure 
of chimeric read. 
INSIGHT INTO SNORNA-DERIVED MIRNAS BIOGENESIS 
 
So far I could deny, to a substantial extent, that C/D-miRNAs are argonaute miRNAs, since the 
snoRNP and DGCR8 CLIP-seq results on U78, U74, and U44, depict a recovery pretty similar to 
the small RNA library clusters. I imagined that this coherent recovery of sRNA could represent 
RNA protection of snoRNPs and DGCR8 during degradation. 
To sort this out, I believed that if they are degradation products, to reduce nuclear RNA 
degradation should decrease C/D-miRNA recovery. The nuclear exosome requires the activity 
of Helicases, for the human exosome the adaptor protein hMTR4 fulfill this function.  
2.1.31 HMTR4 KNOCK-DOWN INCREASES C/D SNORNA EXPRESSION IN HEK293 CELLS. 
 
I decided to analyze the effect of hMTR4 on C/D-miRNA because of its helicase activity and 
especially due to its role as a nuclear exosome adaptor. I used siRNA knockdowns and 
analyzed the small RNA content by NGS.  
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Before sequencing, I tested the knockdown by western blot and quantified levels of known 
hMTR4 substrates PROMPTS (Promoter Upstream Transcripts)55,120,121, knockdowns show 
hMTR4 protein reduction and increase of PROMPTS (Figure 47 A – B), then small RNA was 
purified and sequenced using Ion-Torrent platform.  
The small RNA purification and the library preparation showed similar distribution and quality 
as the control libraries (prepared before 2.1.24), The libraries were aligned to transcriptome 
database and normalized using Deseq package; hierarchical clustering divided the libraries 
between mock and siRNA treated (Figure 47 C).   
The heatmap and fold-change scatter plots show that hMTR4 reduction increases the 
expression of mature snoRNAs, while the C/D miRNAs are unchanged. To see whether this 
observation is similar for the two replicates, I analyzed the mature snoRNA population and 
used miRNAs as controls.  
The independent replicates analysis shows that hMTR4 knockdown significantly increase 
mature snoRNAs, while the miRNAs are kept without changes, interestingly I noted no major 
differences for C/D miRNAs between knockdowns and the controls (Figure 48). 
2.1.32 EXOGENOUS GENOMIC GAS5 INCREASES U78, U44 AND U74 DERIVED MIRNAS. 
 
If these C/D miRNAs perform a particular cellular function in the cells, they might have a 
distinct production pathway, but due to low expression, a stable source is needed to evaluate 
biogenesis and possible functions. 
In 2015 C/D miRNAs HeX proposed that GAS5 encoded the snoRNAs (U74, U75, U76, U77, 
U44, U78, U79, U80), which can be incorporated into Piwi proteins and regulate 
transcription77,78; however they showed results from exogenous expression of the "piRNA" 
from snoRNA expressed outside their intronic context.  
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Figure 47. hMTR4 knock-down increases mature C/D snoRNA expression in Hek293 cells.  
hMTR4 small-RNA analysis. Hek293 cells were transfected with hMTR4 siRNA, smallRNA 
libraries were prepared and sequenced (Ion-Torrent). Three independent control (mock 
transfection) were used for differential expression analysis. (A) hMTR4 knockdown 
characterization by western blot (B). hMTR4 and PROMPT RNA relative quantification by real 
time RT-PCR. Notice the differences on the Y-axis from the replicates. (B) Heatmap 50 more 
expressed genes from the five analyzed libraries. (C) miRNA, snoRNA  (D)  mRNA, snRNA and 
tRNAs fold change between hMTR4 knockdown and control. 
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Figure 48. snoRNA-derived miRNAs are unaffected by hMTR4 knock-down C/D snoRNA 
expression in Hek293 cells. 
Hek293 cells were transfected once and twice with hMTR4 siRNA, and smallRNA libraries 
were prepared and sequenced (Ion-Torrent), three independent control (mock transfection) 
were used for differential expression analysis.(A) Boxplots depict Log2 normalized counts for 
mature C/D snoRNAs and miRNAs and  (B) bar plots compare expression of snoRNA-derived 
miRNAs between controls and siRNA  transfections, in the two experimental replicates. 
 
I thought that an intronic snoRNA overexpression should be the first step to define C/D 
miRNA genesis and possible functionality. For that reason I cloned Gas5 genomic region, 
including of the snoRNA and exons into two CMV promoter vectors, with and without GFP 
(Figure 49). 
I tested the splicing and expression of GAS5 final mRNA and U75; I found that the cells splice 
the exogenous GAS5, confirmed the lncGAS5 lncRNA identity and the distinct splice variants 
by Sanger sequencing Table 14. Using qPCR, I observed that genomic loci transfection 
increases the lncRNA-GAS5 and U75. Establishing that exogenous GAS5 loci (exon-snoRNA-
exon) expression follow the same path as the endogenous snoRNAs, it is spliceosome 
substrate, generating the spliced mRNA (lncGAS5) and individual snoRNAs. Therefore, I 
extracted small-RNA, sequenced Gas5 and compared with untransfected controls, checking 
for quality and evaluating the presence of C/D miRNAs Figure 49 A-C. 
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Figure 49. Genomic GAS5 (gGAS) exogenous expression increases C/D derived miRNAs in 
Hek293 cells  
 Hek293 cells were transfected with GAS5 genomic sequence and analyzed after 72 h.(A)The 
cartoon shows the GAS5 constructs used, arrows represent the forward and reverse primers 
used for PCR. (B)  PCR  gel electrophoresis cDNA from transfected cells: 1) (1) gGAS5, (2) 
Empty backbone and (3) GAS5 plasmid table depicts expected PCR products (representative 
image from three independent experiments). (C) real time RT-PCR for Gas5-lncRNA and U75 
(bar plot from three replicates). (D) gGAS5 exogenous transcript small RNA analysis. Heat map 
for the  30 more expressed genes (E) Scatter plot show relative small-RNAs expression vs. fold 
change Gas5 vs. Control red dots represent (Gas5 encoded snoRNAs). (F) Bar plots show the 
number of Normalized reads for the GAS5 snoRNAs derived miRNAs.  
Ion-Torrent profiling comparison (GAS5 vs. Mock) shows that the Gas5 encoded snoRNA pull 
the snoRNAs up and create a distinct cluster on unsupervised analysis.  GAS5 encoded 
snoRNAs increase over two and four-fold. Also, GAS5 encoded C/D miRNAs increase after 
transfection of exogenous GAS5 expression, but the fold change is not the similar to mature 
snoRNAs.  
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Briefly, the hMTR4 knockdown enhances the recovery of mature snoRNAs as well as the 
exogenous genomic Gas5 expression (for its encoded snoRNA), while the hMTR4 knockdown 
induces no changes in the recovery of C/D miRNAs, the exogenous Gas5 expression increases 
the number of C/D miRNAs on its encoded snoRNAs. However, any conclusion mature 
snoRNAs from the Ion-Torrent profiles performed here should be taken carefully since the 
library preparation is not optimal for mature snoRNAs (Figure 13 and Figure 14). 
 
Table 14  Gas5 spliced variants   
Exon 7 incomplete (7a), Exon 8 and 10 
Exons 5, 8, 9 and 10 
Exon 5, 6, 7, 8, 9, 10 and 11, complete Intron 3, containing 
U76 
Exon 7 incomplete (7a) Exon, 5, 8, 9 and 10 
Exon 5, 8, 9 and 10 
 cDNA from transfected Hek293 cells was clone into p-GEM and sequenced by 
sanger.  Work performed together with Jasmin Preis during her Lab rotation of the 
master Molecular Medicine). 
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3 DISCUSSION 
 
C/D SNORNA-DERIVED MIRNAS-LIKE MOLECULES 
 
snoRNA-derived miRNAs, with less than 30 nt, were initially reported by Ender et al., who 
described that the H/ACA 45 snoRNA loci produces miRNAs. Their evidence indicated that ACA45 
is bound to Ago, it is independent of the microprocessor, and requires Dicer activity; has as its 
putative target CDC2L64.  
Scott and Brameier independently increased the evidence for snoRNA-derived miRNAs, 
determining that C/D snoRNA loci produce miRNA-sized RNA and showing that their distribution 
of reads resembles that of miRNAs, whith a guide and passenger strand. This processing is 
different but conserved among various cell types. Furthermore, many annotated miRNAs carry 
snoRNA-like sequences, while other experimental sources suggest that snoRNAs hold other 
functions including alternative splicing, mRNA post-transcriptional regulation and piwi-RNA like 
activity 71,72,74.  
However, a clear consensus for these “novel” snoRNA features is still in debate, and many 
reviews recommend deeply exploring snoRNA-to-miRNA processing and its presumed 
functionality. 6,7,9-11 
Here, I concentrated on C/D snoRNAs attempting to disprove systematically that C/D-miRNAs 
have canonical miRNA activity. I characterized small RNAs from Hek293 cells using cellular RNA 
and RNP-associated RNA (Figure 7). To evaluate miRNAs endogenous functionality, I developed 
and implemented an analytical flow cytometry assay for miRISC activity in vivo. Using a 
molecular titration model and the R environment, I validated this assay for canonical miRNAs 
and applied to C/D miRNAs (Figure 25).  
Based on the results, it appears intronic C/D-miRNAs are not canonical miRNAs rather 
degradation products. It is important to examine how the 5'  domain of U3 (C/D snoRNA) 
produces canonical miRNAs and propose (hypothetically) that U3-derived miRNAs are in fact 
regulators of rRNA biogenesis.  
I will also explain how analytical flow cytometry can be utilized as a high-resolution sensor of 
endogenous miRNA activity, including further applications and comparison with similar tools. 
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3.1.1 C/D SNORNA-DERIVED MIRNAS DIFFER FROM CANONICAL MIRNAS. 
 
I applied a deductive approach to characterize C/D-miRNA; disproving rather than confirming a 
hypothesis, this empirical falsification works by establishing a set of testable predictions that 
would reject the hypothesis. My hypothesis claims that C/D-miRNAs functionally operate as 
canonical miRNAs, which reduces the scope to classic Ago-dependent regulation and discards 
other miRNA mechanisms. Using the miRNA paradigm as theoretical predictor I set up the 
following  “diagnostic criteria" for miRNAs”: 
1. miRNAs are shorter than 25 nucleotides 8,112. 
2.The miRNAs guide and passenger strands can be detected in small RNA libraries 114. 
3.miRNA-function depends on Argonaute, which thus should interact with canonical 
miRNAs101. 
4. Dicer processes the vast majority of pre-miRNAs and their hairpin structure can be 
defined 100,114. 
5. DGCR8 processes pri-miRNA, so miRNAs should be recovered from DGCR8-bound 
RNAs 59,99. 
6.They should act according to the molecular titration model in analytical flow 
cytometry 119,122,123. 
7. miRNA targets can be identified from Chimeric reads on immunoprecipitated NGS 
data. 
Table 4. Summary of functional criteria for selected C/D snoRNA-derived miRNAs.   
Candidate miRNAs ACA45 U3 U78 
 
U44 
 
Section in 
the 
dissertation 
Length <25 + + + - - 2.1.24.1 
Cytopasmic + + + - - 2.1.24.3 
Guide strand cluster + + + + + 2.1.24.1 
Argonaute + + + - - 
2.1.24.4 Dicer + - + - - 
DGCR8 + + + + + 
Threshold sharpening + + + + - 2.1.28 
Shift after outcompeting + + + - - 2.1.29 
Described Targets + +* + - - 2.1.30 
Table 15 miRNA features evaluated in this study.  
Length and strand clusters small RNA Seq. 
Argonaute, Dicer, DGCR8 CLIP Seq. 
Analytical flow citometry (threshold and outcompetition) 
Targets from CLASH chimeras call. 
*Described in 4  
 
 
First, I evaluated the small RNA content of Hek293 cells using NGS (Ion-Torrent). All libraries 
correlated positively with a high Pearson coefficient, hold comparable read distribution and a 
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large number of miRNAs were recovered (Figure 8). The correlation and sno/miRNA distribution 
match the data sets derived from GEO data sets. 
The libraries retrieved different snoRNA classes and subclasses (mature and miRNAs), without an 
exact correlation between the mature snoRNA (~70 nt) and small fragments (<40 nt) (Figure 9), 
suggesting that C/D miRNAs might have a different source, assuming that the abundance of 
degradation products should be proportional to that of the mature snoRNAs.  
To discern the differences between C/D miRNA processing and degradation products, I used a 
simple unsupervised analysis (hierarchical clustering), differentiating C/D miRNA coherent 
processing and degradation112. The hierarchical clustering defines a distinct beginning and end 
for C/D mature and derived-miRNA (Figure 10), facilitating the selection of small RNA with 
coherent processing. 
Using hierarchical clustering and expression analyses, I selected six snoRNA candidates to 
evaluate as a source of miRNAs: U78, U74, U44, snR39, and U3. I chose ACA45 as a positive 
control for snoRNA-derived miRNAs because it appered in the clustering analysis, and it has 
been described as an miRNA 4 (Figure 11).  
Candidates’ clusters (hierarchical clustering of reads) show the guide and passenger strand 
distribution observed for miRNAs 112, but the read length differs from canonical miRNAs. The 
mean read length for U78, U74, U44, and snR39B is longer than 25, while the controls and U3-
derived miRNAs are shorter than 25 (Figure 11). This suggests that the intronic C/D miRNAs are 
bigger than the canonical miRNAs and probably can be interpreted as piwi-RNAs 124 .  
The differences in recovery of mature snoRNAs versus further processed miRNAs (< 40 nt) 
indicate that the latter might have a distinct production mechanism, because the highly 
expressed long snoRNAs have no processed counterpart.  
Since there was a possibility that libraray preparation introduces a bias that could explain the 
forehead mature-miRNA/snoRNA distribution. I checked various library preparations and 
observed that the ethanol-based purification (used for the Ion-Torrent) poorly recovers mature 
snoRNAs, and PAGE-based separation (20-200) improves canonical snoRNA retrieval (Figure 14 
B). The C/D miRNA number is just a small fraction of the whole snoRNA population, and their 
expression is proportional to mature snoRNAs (Figure 14 D), suggesting that C/D miRNAs levels 
are low in basal culture conditions.  
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Furthermore, C/D miRNAs are differentially located within cell. Canonical miRNAs are mainly 
cytoplasmic and the majority of the C/D snoRNAs are nucleolar and nucleoplasmic, except for 
ACA45 and U3, which are also found in the cytoplasmic fraction (Figure 15). A biochemical 
characterization observed a similar distribution of mature snoRNAs inside the nucleus, and 
showed no methylation modifications over mRNA. However, it is unclear whether this effect 
could distinct between the short and  long fragments76.  
From small RNA libraries, I showed that C/D miRNAs are weakly expressed and located mainly in 
the nuclear compartment. Their clustering resembles the miRNA guide/passenger strand 
recovery, and their mean read length is approx. 25 nt, indicating a distinct role and probably 
putting them closer in nature to piRNAs than to canonical miRNAs (Discussed in 3.1.3). Briefly, 
this revealed that C/D snoRNA candidates do not follow the behavior of miRNA controls (miRNAs 
and ACA45-miRNA), except for U3, which is not intronic but is bigger (217 vs. 70) than the other 
C/D snoRNAs. 
 Argonaute CLIP and RIP seq analyzed data did not contain the intronic C/D snoRNA candidates 
(U78, U44, U74, snRN39B), but recovered ACA45 and U3. Also, Argonaute-bound miRNAs are 
distributed similarly to the miRNAs contained in the small RNA profiles (Figure 17 and Figure 18). 
I observed a lack of the intronic candidates in Dicer PAR-CLIP data (Figure 20).  
For DGCR8, I recovered C/D snoRNAs and miRNAs (Figure 21). Interestingly U78 recovered reads 
resemble the processing cluster of small RNA profiles (Figure 22), suggesting that the C/D 
miRNAs could be RNP interactions, particularly in terms of DGCR8 protection of U78 until it is 
degraded. (See below 3.1.3)  
From analytical flow cytometry, U78 shifts the analytical function, without being outcompeted 
by siRNA, implying that this performance is miRNA independent (Figure 43 and Figure 45). I 
cannot discount the possibility that the U78 inserted site can be modified by the mature U78 
and affect CFP translation, analogously to snoRNA base vectors that downregulate 
complementary mRNA by introducing its sequence between the C and D boxes80, or to 
endogenous snoRNAs that modify the steady state of mRNAs (as described from LIGR-seq)79. 
If U78 is responsible for miRNA-independent CFP regulation, a CRISPR knockout of U78 should 
not lead to molecular repression in analytical cytometry measurments, and different 
experiments could elucidate putative snoRNA-mRNAs regulatory mechanism. 
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3.1.2 5' U3 DOMAIN SOURCE OF MIRNAS 
 
Based on their length (above 25 nt), poor interaction with Argonaute and Dicer, and their 
endogenous functionaly, there is no evidence that C/D miRNas perform miRNA-like regulation. 
 
Figure 50.  U3 structure and 5’domain miRNP interaction 
(A) Schematic U3 snoRNP structure, RNA is shown in black and protein organization is indicated 
63. (B) Summary of the model described here, notice that only the 5’ U3 domain was recovered in 
miRNPs. 
 
However, for the 5' domain of C/D snoRNA, which contains a GAC box, the Box A and A'; and a 5' 
and 3' hinge, I recovered miRNAs of 22 nt read length and found them in the cytoplasm (Figure 
15 and Supplementary Figure 6). For miRNP, I found that the U3 5' domain miRNA (5' 46-64 3') 
bound to several Ago IP preparations (Figure 18, Figure 23 and Figure 24), and it interacted with 
Dicer and DGCR8. 
Dicer PAR-CLIP data recover almost the complete 5' region, and Dicer read distribution shows a 
hairpin structure fitting with the folded 5' domain (Figure 24). Moreover, analytical flow 
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cytometry registered that the U3 miRNA (5' 46-64 3') behaves similarly to low expressed miRNAs 
like ACA45 or miR-451-3p. (Figure 44 and Figure 45) 
Furthermore, the chimeric call from CLASH data recovered miRNA targets for 5' U3 domain 
derived-miRNAs, including Nop58 and ATXN2, hinting that this region yields functional miRNAs 
(Figure 46).  
I posit that that U3 could be ncRNA with dual activity and since it is the center for the early steps 
of rRNA processing, I presume that if it is also a source of miRNAs, it might regulate proteins 
related to ribosome biogenesis.  
This hypothesis requires experimental inquiry, so I will describe what I consider to be the pivot 
point between snoRNA and miRNAs, including empirical outlines that could disprove the 
hypothetical mechanism.  
U3 snoRNA associates with the canonical snoRNP Nop56, Nop58, and Fibrillarin (Figure 21 and 
Figure 23), and its unique interacting factor U3-55k, which binds to the distinct U3 motif B/C 
44,61. Importantly, the distribution of the mammalian snoRNP is analogous to the snoRNPs 
location  in the yeast U3 (compare Figure 23 with CRAC data)111.  
Studies in U3 biogenesis suggested that U3 does not have a cytoplasmic phase and goes through 
the Cajal body, even though U3 interacts with the nuclear export factors PHAX and CRM160,125. 
Additionally, the interaction with U3-55K is needed for nucleolar location63,115,126, including 
several trans acting factors interacting during biogenesis 125.  
However, certain circumstances change the U3 cellular location. For example, in the absence of 
proper C, C' D or B boxes, the U3 is not retained in the nucleolus and could end in the 
cytoplasm61,69. Foremost in starvation, U3 move to the cytoplasm68. Probably U3 location might 
be a ribosome biogenesis pivot control. I would consider it possible that during starvation, the 
U3 moves into the cytoplasm and becomes a Dicer substrate, creating functional miRNAs that 
down regulate Nop58. 
Recently, Chen et al. reported that hypotonic stress reduces ribosome biogenesis by U3 55K 
hyperacetylation, leading into a decreased interaction with U3 64. Also, epithelial differentiation 
reduces ribosome biogenesis, and this seems to depend on U3 and U3-55K expression because 
during differentiation, U3 snoRNA and U3-55k levels are significantly smaller than 
undifferentiated controls 63.  
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On the miRNA front, starvation increases the expression of group V miRNAs (Drosha 
independent and PHAX-CRM1 dependent), overcoming group I miRNAs (Drosha-Exp5) by 
reducing Exp5 expression. This suggest that PHAX-EXP1-dependent miRNAs are specific for 
stress conditions and governed at the nucleocytoplasmic transport29. 
Based on this information, I speculate that this model is possible: 
 
Figure 51. Hypothetical model for U3 derived miRNAs 
hU3-55K controls U3 levels and regulates ribosome biogenesis 63,64, while U3 steady state levels 
are controlled post-transcriptionally  127. In cases of differentiation or stress, hU3-55k probably 
interacts less with U3, allowing it to enter the miRNA pathway, where it could manage stress 
responses by regulating Atxn or stopping ribosome biogenesis by reducing Nop56. 
 
Stress or differentiation induce post-transductional changes a to the U3-55k protein and reduce 
its interaction with U3. Simultaneously, the miRNA machinery recognizes the U3-55k-free 
snoRNA and produces miRNAs transported into the cytoplasm by the PHAX-Exp1 pathway. In the 
cytosol, Dicer processes the hairpin and yields double-stranded RNA included in Ago. Since the 5' 
contains a methyl-cap, just the 3' strand is selected and regulates stress proteins like ATXN2 or 
snoRNPs 
The evidence in this dissertation and the literature together provide feasibility to the model, 
giving predictive power to test experimentally and disprove or reconsider the hypothesis. 
First, U3 5' domain exogenous expression should produce functional miRNAs, either using shRNA 
(pol III promoter) or pol II-driven vectors. Second, decreasing U3-55K RNA protein interaction 
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should increase U3-derived miRNAs. Experimentally, one should use U3 exogenous expression 
with modified B/C and C'/D motifs or knock down U3-55k protein. Finally, stress conditions or 
differentiation should reduce U3-55K expression increasing U3 miRNA generation. 
In conclusion, U3 5' domain is a bona fide miRNAs locus, and U3-55K protein probably controls 
U3 fate. If the cell needs ribosomes U3-55K bound to U3 allows the 80 SSU (small subunit) 
processome formation, while in case of differentiation or starvation, U3-55K interaction is 
reduced permitting U3 to enter the miRNA pathway trough the PHAX and CRM1 pathway. 
3.1.3 C/D MIRNAS DEGRADATION VS. FUNCTIONALITY. 
 
 miRNA "diagnosis criteria" do not apply to intronic C/D miRNAs (Table 15), insinuating the 
improvability that C/D miRNAs operate as canonical miRNAs. What  can we say about their role? 
And how good is the evidence providing biological explanations?  
Here are two perspectives on C/D miRNAs: one as alternative to miRNAs (piRNAs), and the 
second that posits they are degradation remnants.  
In 2015, He et a.l found small RNAs derived from the Gas5 locus and proposed them to be 
piRNAs77, similarly to my description for small RNA profiles (Figure 11), exposing differential 
expression between tumor and normal tissues, and presuming that these "sno-piRNAs" regulate 
transcription through epigenetic mechanisms. 
My primary concern refers to their exogenous expression experiments, which were performed 
with constructs containing only the snoRNA gene without flanking exons. Also, I replicated the 
loop PCR they used and found that their recommended primers cannot accurately differentiate 
between the "piRNA" and the mature snoRNAs (data not shown). They continued describing 
snoRNA-derived piRNAs with a similar set of techniques78. 
The differential expression of tumor-normal tissues77 (or in activation of lymphocytes 78) could 
be explained alternatively by different ribosome needs as for undifferentiated vs. differentiated 
63,77. Their conclusion could be exemplified as a problem of induction, where true premises 
(arguments, in this case, sound experiments) lead to false conclusions. To clarify: their 
experiments also prove other scenarios and are not restricted to "piRNAs". 
piRNAs are an excellent functional alternative since they are bigger than miRNAs (Figure 11 C). 
However mechanistic experiments are needed to overcome the biological and technical 
weaknesses from 77. At the moment, I know that the exogenous expression of the genomic Gas5 
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increases the number of C/D miRNAs and it will probably be a good starting point to develop 
(Figure 49). 
C/D miRNAs can also be discussed as degradation remnants. Assuming that sRNA-seq reads 
reflect RNP protection, which holds true for miRNAs in Ago and Dicer, I recognize that DGCR8 
snoRNA distribution for U78 is similar to the reads recovered in small RNA libraries, including the 
patterns from snoRNPs PAR-CLIP data sets (Figure 22). 
To test whether C/D miRNAs are degradation products, I evaluated their production upon 
reducing the exosome adaptor hMTR4, and observed an increase in mature snoRNAs without 
affecting the C/D miRNAs production, challenging the ideas of degradation products (Figure 47 
and Figure 48). However, HITS-CLIP and mass spectrometry for DGCR8 showed that the 
microprocessor is an adaptor of the nuclear exosome too, explaining how hMTR4 could not 
affect the C/D miRNAs.  
These two speculated scenarios not mutually exclusive, and require experimental evaluation 
using risky predictions and deductive falsification (as performed here for C/D miRNAs). This  
might give evidence to disprove the idea that they are piRNAs or degradation products.  
3.1.4 ANALYTICAL FLOW CYTOMETRY HIGH-RESOLUTION PLATFORM FOR MIRNAS 
FUNCTIONALITY. 
 
The underlying assumption in deep sequencing studies is that miRNA quantification reflects 
miRISC activity because small RNA libraries display Ago2 RNA stabilization, 128,129 and Ago2 
stability depends on miRNA abundance 130,131 . 
The dynamic function of miRNAs introduces uncertainty into small RNA profiling. For example,  
Ago 1–4 proteins are less abundant than miRNA molecules, so the cell deals with Ago sub-
stoichiometric levels by multiple recruitments to free miRNA-mRNA complexes 132, suggesting 
that cellular profiles contain also non-protein bound mRNA-miRNA molecules. 
At the functional level, lentiviral-based high-throughput experiments showed a breach between 
silencing and expression 41,133, because more than 50% of miRNAs hold no detectable activity, 
meaning that they are working or that the sensor resolution is weak. Moreover, many highly 
abundant Ago2-bound small RNAs showed no inhibitory activity 41,102,134. 
Considering that various studies tested miRNA functionality using luciferase-based assays, and 
those experiments had low resolution and narrow detection limit41,102,134. I reasoned that a high-
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resolution assay for miRNAs functionality was required. Terefore, I generated and validated a 
single plasmid fluorescent reporter to use for individual cell measurements. 
To establish the raw data from individual cell measurements (around 50.000 cells per miRNA), 
we adapted, tested and validated a molecular titration model (Figure 28 and Figure 31). This 
model was tested only for miR-20a and involved a TET dependent bi-directional promoter, 
demanding cell selection and the concomitant expression of the tetracycline repressor 44, 
showing the need for at least two plasmids and a lot of work.  
The single plasmid simplifies the experimental workflow and expands the model to other cell 
types. The dual fluorescence system uses standard constitutive promoters (Tk and SV40, Figure 
25,Figure 26 and  
Table 1), enables quantification by flow cytometry (Figure 27) and reproduces the results 
obtained in luciferase assays for the same miRNA candidates (Figure 27 and  Supplementary 
Figure 8). 
Regardless of the differences among the fluorescent sensor used by Mukherji et al.44, the results 
of the Gl-2 siRNA experiments that modulated the threshold-linear response (through different 
binding sites) and shifted the function (increasing siRNA concentration) agreed with the 
simulated model predictions (Figure 33 and Figure 34). More convincingly, this applies 
exceptionally to endogenous miRNAs (Figure 38 and Figure 39). 
Interestingly, our sensor disconnects miRNA silencing from their expression (Figure 38 and 
Figure 35) and we observed a significant difference between low and high functional groups 
(Figure 38 D), which might associate with the detection threshold for luciferase-assays (1000 
reads (~9 log2 scale)) 134. I cannot reject that stabilizing mechanism might also change the ,into P 
bodies135,136, or a different ratio of miRNAs to target mRNAs41.  
We considered that the analytical flow cytometry could generate hypothesis for Ago2 
functionality in vivo. As proof of principle, we tested how the miRNAs subcellular location 
influences their function. Using HeLa cells, we showed that some low functional miRNAs are 
nuclear, while highly active miRNAs are in the cytoplasm (  Figure 40).  
Several studies indicate that many small RNAs associate with Ago24,74,134,137,138, lacking proper 
functional readouts. For instance, they use either luciferase assay4,74,134or artificial exogenous 
expression 77,78,139, suggesting that the real physiological role is still undefined and contradictory 
in the literature 10,76-78,140-142.   
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Furthermore, threshold modulation and out-competing miRNAs allowed the analysis of low 
expressed miRNA functionality. For example, U3 5' domain and ACA45 replicate the behavior of 
miR-451a-3p, while U78 shows regulation independent of Ago (Figure 43,Figure 44 and Figure 
45). I consider that molecular titration models in combination with FACS analysis could evaluate 
expanded processes, like protein or nucleic acid degradation, producing in vivo quantitative 
outputs that might increase the analytical toolbox for cell biologists. 
Finally, our reporter system (in combination with its data analysis) quantitatively measures 
miRNA activity, defining parameters equivalent to dissociation constants and concentrations, 
thus empowering high-resolution quantitative assay for miRNA functionality, bringing a better 
and sounder picture of miRNA-induced regulation in vivo. 
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4 SUMMARY. 
 
U3 is the exception for snoRNA’s canonical functionality. It is transcribed independently, guides 
rRNA early cleavage, and requires a unique set of interacting proteins. Structurally, U3 has two 
functional domains, the 5’ domain, which has the A box and two hinge regions and interacts 
with the rRNA 5’-ETS, and the 3’ domain that interacts with the classic snoRNPs -Nop56, Nop58, 
15.5K and Fibrillarin- and its unique protein U3-55K. This interaction requires the sequence motif 
B/C, C’/D and a secondary structure that allows a correct cellular location. 
U3 controls ribosome biogenesis and its activity evolved as an intricate regulation. For example, 
cells with low de novo ribosome synthesis, such as final differentiated cells, reduce U3 synthesis 
by controlling U3-55K transcription. Additionally, stress-induced U3-55K acetylation reduces U3 
stability, while starvation pulls U3 out  of the nucleoli, its main location, into the cytoplasm.  
Recently, NGS evidence expanded small RNA regulation beyond the accepted miRNAs and 
introduced RNAs with double function. For instance tRNA and H/ACA snoRNAs can produce 
small RNAs that effectively bound to Ago proteins (The main miRNA’s effector). While C/D 
snoRNAs produce small fragments, its functionality still unclear and contradicting. To 
characterize functionally C/D snoRNAs derived small RNAs (s-sno-RNAs) we generated small RNA 
libraries from Hek293, and analyzed snoRNP and miRNPs CLIP data. 
To rule out that C/D snoRNAs perform miRNA activity, I checked for miRNAs biochemical, 
structural and functional features, and discarded intronic C/D s-snoRNA as a source of miRNAs. 
The most expressed ones in our profiles (U78, U44 and U74) have a mean length between 26 
and 27 nts, are not found in miRNPs and do not perform posttranscriptional regulation. 
Meanwhile canonical miRNAs and ACA45 miR-snoRNA, -H/ACA with miRNA function- have a size 
betwen 19-21 nts, interact with Ago and show posttranscriptional repression (see below).  
Surprisingly, I could not discard U3 as a source of miRNAs. We found products between 21 and 
23 nt in our libraries, and in several Ago RIP and CLIP data, suggesting that it can produce 
functional miRNAs. But its low expression made classic functional assay (luciferase reporter) 
inquires unreliable, because their noise-to-signal resolution is lower than next generation 
sequencing techniques.   
The luciferase resolution made small expressed miRNAs undetectable, misleading conclusions 
about functionality. To increase the resolution I designed a reporter-assay based on two 
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fluorescent proteins (Un-translated trans assay, UTA), where one works as reference while the 
other contains a miRNA-complementary target region. 
 Using analytical flow cytometry, which includes a molecular titration model and R environment 
data analysis, I increased the resolution to single cell level and evaluated it in combination with 
small RNA profiles derived from NGS. The model predicted three distinct groups of miRNAs with 
unique repression activities (low, mid and high) governed by expression and miRISC formation 
rates.  
I confirmed the model’s feasibility, employing controlled concentrations of a non-human 
targeting siRNA and increasing miRNA complementarity on the sensor protein.  Using 30 
individual human miRNA candidates with various expression levels, we validated this technique 
as a high-resolution analytical tool for miRNAs repression activity.  
I used the model prediction for low functional miRNAs and tested it for endogenous snoRNA-
derived miRNA, as predicted: the control (miRNA-451a) showed small changes after increasing 
bind and outcompeting with siRNAs. The snoRNA-derived miRNAs, ACA45 and U3, performed 
similarly to the canonical miRNA.  
U3 5’ domain derived-miRNAs have a secondary structure that fits as a Dicer substrate, the 
predicted loop from thermodynamic folding is poorly represented in Dicer CLIP pools. 
Furthermore, low base pairing energy at the distal U3 5’ domain predicts its 3' end as guide 
strands and Ago CLIP data confirms this prediction. 
Since U3 5’ derived miRNAs are low expressed, I confirmed its functionality with my high-
resolution tool and showed, as the mathematical model predicts, that U3 in basal conditions 
works a low functional miRNA. Additionally calling chimeric reads from CLASH data, I found four 
mRNA targets including Nop58 and ATXN.  
Other experiments ought to be employed to confirm targets regulation, including U3 5’ domain 
expression without the 3’ domain (snoRNPs interaction domains) and using mutated C,C’ and D 
boxes (U3-55K binding). Also, stress conditions that regulate ribosome biogenesis and U3 
expression, need to be tested to rule out that U3 is a moonlight non-coding RNA that regulates 
cellular stress response by generating miRNAs.  
In conclusion, I can assure that intronic snoRNAs are rarely a source of miRNAs, that analytical 
flow cytometry increases the resolution and evaluates post-transcriptional regulation of low 
expressed endogenous miRNAs. Additionally, I have evidence that predicts U3 5’ domain as a 
source of miRNAs, which needs to be confirmed and mechanistically explored. 
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Supplementary Figure 1 Total RNA and small RNA libraries quality from Hek293 cells 
Three independent total RNA isolations were performed and RNA integrity tested by 
BioAnalyzer System (A). If RNA integrity number (RIN) was higher than 9 (B) Ion Torrent 
small RNA library preparation were performed and quantified and (C). Diluted library (18 
pM) was sequenced via Ion-Torrent System. 
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Supplementary Figure 2 Processing analysis of snoRNA locus 
 (A) Manual analysis on genomic tracks   (B) No clustered vs Clustered reads  
 
 
 
Supplementary Figure 3 snoRNA-derived miRNA processing and counts distribution 
Counts distribution for three libraires, box plot showing normalized counts and location within the 
snoRNA locus, and density plots for miRNAs as example and the snoRNAs as read length.  
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Supplementary Figure 4 U78 northern blot optimization.  
Conditons used for U78 derived miRNA detection, using synthetic RNA, the blots show different 
probe concentrations and incubation temperatures.  The blots plot different synthetic RNA and 
probe concentration. The concentration limit for U78 is pull down to 50 pg.  
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Supplementary Figure 5 HeLa small RNA libraries quality and correlation.   
Total RNA quality and small RNA selection bioanalyzer, Read distribution from Ion-Torrent 
server and correlation between Dr. Böker and GSM50057 libraries.  
 
Supplementary Figure 6 U3 derived microRNA HeLa subcellular fractions 
Density plots show read distributions from subcellular location derived NGS data (GSM50057) 
and the control performed in this thesis (Sequencing performed by Dr. Kai Böker).(A) Density 
plot U3 nucleotide positions as function of Percentage of Maximum and (B) U3 5’ Domain 
density plot. 
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Supplementary Figure 7 Argonaute libraries correlation  
Correlation matrix plot of RIP and CLIP Argonaute data, circules represent the Pearson 
correlation and color code are located at the left side  
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B 
 
 Supplementary Figure 8 UTA-3. Dual Fluorescence Reporter System functionally 
characterized miRNA activity by microscopy. 
 Untranslated Trans Assay (UTA) uses two independent fluorescent proteins expressed 
individually from two different promoters. RFP contained a perfect complementary target 
region for miRNAs within its 3’ UTR while GFP is unaffected. Human HEK293 cells were 
transfected with three different sensor constructs (miR-23a-3p, miR-27a-3p and Non-cognate 
as control) and evaluated after 72 h. (A) Micrographs display variety of GFP and RFP 
expression in all the samples within a broad range of fluorescence intensities. Micrographs 
were taken with the same exposure time and with 10X objective. (B) Decreased ratios CFP/YFP 
for miRNA-targeted constructs from bulk quantitative analysis: pictures were analyzed with 
ImageJ and relative fluorescence intensity ratios ( RFP and GFP) for miRNA 23a-3p, miRNA 
27a-3p and the non-cognate control were calculated using custom R scripts and imageJ.  
(Transfections performed together with Ignacio Rodriguez during his Research internship under Lemus Supervision). 
 
 
 
 
Supplementary Figure 9 Analytical flow 
citometry: Non cognate controls 
Several non-cognate controls were 
inserted on UTA-2 plasmids and 
evaluated on Hek293 cells 72 h post 
transfection  
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Supplementary Figure 10 Transfection standardized conditions. 
Several transfection using increasing concentration and collection times, Upper 24 and 48 
hours, and bottom 72 h. Concentration are depicted.      
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Supplementary Figure 11 Functional miRNA characterization  
Hek293 cultures were  sequenced by  Ion-Torrent  platform and  (A)  twelve different miRNAs were 
selected based on their expression levels (Mean Normalized Counts) and quartile position. 12 
different reporters were generated and functionally tested using FACS. Analytical transfer function 
for candidates located: (B) below the first quartile, (C) between the median and the first quartile, (C) 
above median and the third quartile;  (D) above the third quartile.      
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Supplementary Figure 12 Post-transcriptional miRNAactivity from analytical flow cytometry in HeLa 
cell.   
GEO50057 retrieved raw data from HeLa small – RNA seq experiment was retrieved and compared 
with fresh produced total cell small RNA library (Raw data produced by Dr. Kai Böker). Fractionated 
cell compartment derived small RNA libraries were used for further analysis of nuclear, cytoplasmic 
and nucleolar content. (A) Experimental layout for HeLa small RNA library preparation in 
GSE50057 and Dr. Böker. miRNAs reporters were transfected into HeLa cells, evaluated after 72 h and 
(B) analytical functions were plotted. (C) Functions distributed into three ordinal variables as before 
(Figure 35) and cellular normalized counts were compared between groups (P < 0.01 Kruskal-Wallis 
test, Dunn’s multiple comparisons test * < 0.05) 
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Supplementary Figure 13 Analytical flow cytometry  
 
Seed, motif, seed+ motif or complete for miR92a were inserted in the dual fluorescent construct 
and tested for analytical flow cytometry. 
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PLASMID USED AND GENERATED IN THIS THESIS. 
 
 
 
 
 
 
 
 
 
Plasmid Obervations 
p.UTA.1.0 Empty Also GL-2, miR23 amd mir27 
p.UTA.2.0 Empty. All oligos in Supplementary Table 4 
p.UTA.3.0 Empty Oligos for 10 miRNAs 
pGEM-Gas5 2 clones with distinct oritation 
pTarget-Gas5 TA cloning 
pGEM-lncGAS5  10 different splice variants 
pAcGas5-GFP As described in methods 
Supplementary Table 1 Generated plasmid 
Plasmid Source 
pLenti-CaMKIIa-eArchT 3.0-EYFP gift from Karl Deisseroth (Addgene 
plasmid # 35513) 
pcDNA3-CFP Gift from Doug Golenbock (Addgene 
plasmid # 13030 
 
psiCheck2 Promega 
pAcGFP-N1 Clontech 
pGEM-T-Easy Promega 
pTarget Promega 
Plemir-RFP Dharmacom 
psiCheck2 mir23  Cloned by Henricke  Höke 
 
psiCheck2 mir27 Cloned by Henrike  Höke 
 
Supplementary Table 2 Used plasmids in this thesis 
 
Plasmid Addgene ID 
p.UTA.2.0 miR-27a-3p 82438 
p.UTA.2.0 miR-27a-3p 3 perfect copies. 82439 
p.UTA.2.0-GL-2 82440 
p.UTA.2.0-GL-2-3 perfect copies 82441 
p.UTA.2.0 miR 19b-3p 82442 
p.UTA.3.0 miR-21-5p 82445 
p.UTA.2.0 Empty 82446 
p.UTA.3.0 Empty 82447 
Supplementary Table 3 Public available plasmids: submitted at https://www.addgene.org 
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OLIGO SEQUENCES USED FOR MIRNA ANALYSIS AT SINGLE CELL LEVEL 
 
miRNA oligos  (5’-3’ xhoi or noti overhangs) 
hsa-miR-100-5p ggccagcttctttacagtgctgccttg 
 tcgacaaggcagcactgtaaagaagct 
hsa-miR-1301-3p ggcctgcagctgcctgggagtgacttc 
 tcgagaagtcactcccaggcagctgca 
hsa-miR-215-5p ggccatgacctatgaattgacagac 
 tcgagtctgtcaattcataggtcat 
hsa-miR-28-3p ggcccactagattgtgagctcctgga 
 tcgatccaggagctcacaatctagtg 
hsa-miR-29a-3p ggcctagcaccatctgaaatcggtta 
 tcgataaccgatttcagatggtgcta 
hsa-miR-24-3p ggcctggctcagttcagcaggaacag 
 tcgactgttcctgctgaactgagcca 
hsa-miR-451a   ggccaaaccgttaccattactgagtt 
 tcgaaactcagtaatggtaacggttt 
hsa-miR 7-5p   ggcctggaagactagtgattttgttgt 
 tcgaacaacaaaatcactagtcttcca 
hsa-miR-15a-5p   ggcctagcagcacataatggtttgtg 
 tcgacacaaaccattatgtgctgcta 
hsa-miR-16-5p   ggcctagcagcacgtaaatattggcg 
 tcgacgccaatatttacgtgctgcta 
hsa-miR-19b-3p   ggcctgtgcaaatccatgcaaaactga 
 tcgatcagttttgcatggatttgcaca 
hsa-miR-26a-5p   ggccttcaagtaatccaggataggct 
 tcgaagcctatcctggattacttgaa 
hsa-miR-29b-3p ggcctagcaccatttgaaatcagtgtt 
 tcgaaacactgatttcaaatggtgcta 
hsa-miR-93-5p ggcccaaagtgctgttcgtgcaggtag 
 tcgactacctgcacgaacagcactttg 
hsa-miR-103a-3p ggccagcagcattgtacagggctatga 
 tcgatcatagccctgtacaatgctgct 
hsa-miR-148a-3p     ggcctcagtgcactacagaactttgt 
 tcgaacaaagttctgtagtgcactga 
hsa-miR-181a-5p ggccaacattcaacgctgtcggtgagt 
 tcgaactcaccgacagcgttgaatgtt 
hsa-miR-221-3p ggccagctacattgtctgctgggtttc 
 tcgagaaacccagcagacaatgtagct 
hsa-let-7c-5p ggcctgaggtagtaggttgtatggtt 
 tcgaaaccatacaacctactacctca 
hsa-miR-18a-5p ggcctaaggtgcatctagtgcagatag 
 tcgactatctgcactagatgcacctta 
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hsa-miR-19b-3p ggcctgtgcaaatccatgcaaaactga 
 tcgatcagttttgcatggatttgcaca 
hsa-miR-25-3p ggcccattgcacttgtctcggtctga 
 tcgatcagaccgagacaagtgcaatg 
hsa-miR-125a-5p ggcctccctgagaccctttaacctgtga 
 tcgatcacaggttaaagggtctcaggga 
hsa-miR-500a-5p ggcctaatccttgctacctgggtgaga 
 tcgatctcacccaggtagcaaggatta 
hsa-miR-340-5p ggccttataaagcaatgagactgatt 
 tcgaaatcagtctcattgctttataa 
hsa-miR-671-5p ggccaggaagccctggaggggctggag 
 tcgactccagcccctccagggcttcct 
hsa-miR-3607-5p ggccgcatgtgatgaagcaaatcagt 
 tcgaactgatttgcttcatcacatgc 
hsa-miR-3607-3p ggccactgtaaacgctttctgatg 
 tcgacatcagaaagcgtttacagt 
hsa-miR-21-5p ggcctagcttatcagactgatgttga 
 tcgatcaacatcagtctgataagcta 
hsa-miR-27a 3p ggccttcacagtggctaagttccgc 
 tcgagcggaacttagccactgtgaa 
hsa-miR-27a 3-p b   
bulged 
ggccttcacaggtctaagttccgc 
 tcgagcggaacttagacctgtgaa 
GL-2 ggcccacgtacgcggaatacttcgaaa 
 tcgatttcgaagtattccgcgtacgtg 
GL-2 bulged ggcccacgtacgcggtctacttcgaaa 
 tcgatttcgaagtagaccgcgtacgtg 
U78 ggccatgtagacaaaggtaacact 
 tcgaagtgttacctttgtctacat 
U3 1 ggccaagtttctctgaacgtgtag 
 tcgactacacgttcagagaaactt 
U3 2 ggccaccacgaggaagagaggtag 
 tcgactacctctcttcctcgtggt 
U3 3 ggccggagagaacgcggtctgagt 
 tcgaactcagaccgcgttctctcc 
ACA45 ggccaaaggtagatagaacaggtc 
 tcgagacctgttctatctaccttt 
U44 ggcccctggatgatgataagcaaa 
 tcgatttgcttatcatcatccagg 
GL-2 3 copies ggcccacgtacgcggaatacttcgaaaccggcacgtacgcggaatacttcgaaaccggcacgtacgcggaatacttcgaaa 
 tcgatttcgaagtattccgcgtacgtgccggtttcgaagtattccgcgtacgtgccggtttcgaagtattccgcgtacgtg 
hsa-miR-27a 3p 3 
copies ggccttcacagtggctaagttccgcccggttcacagtggctaagttccgcccggttcacagtggctaagttccgc 
 tcgagcggaacttagccactgtgaaccgggcggaacttagccactgtgaaccgggcggaacttagccactgtgaa 
hsa-miR-27a 3-p b   
bulged 
tcgagcggaacttagacctgtgaaccgggcggaacttagacctgtgaaccgggcggaacttagacctgtgaaccgggcggaacttag
acctgtgaa 
 ggccttcacaggtctaagttccgcccggttcacaggtctaagttccgcccggttcacaggtctaagttccgcccggttcacaggtctaag
ttccgc 
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U78 ggccatgtagacaaaggtaacact 
 tcgaagtgttacctttgtctacat 
hsa-miR-451a   ggccaaaccgttaccattactgagttccggaaaccgttaccattactgagttccggaaaccgttaccattactgagtt 
 tcgaaactcagtaatggtaacggtttccggaactcagtaatggtaacggtttccggaactcagtaatggtaacggttt 
hsa-miR-15a-5p   ggcctagcagcacataatggtttgtgccggtagcagcacataatggtttgtgccggtagcagcacataatggtttgtg 
 tcgacacaaaccattatgtgctgctaccggcacaaaccattatgtgctgctaccggcacaaaccattatgtgctgcta 
hsa-miR-19b-3p ggcctgtgcaaatccatgcaaaactgaccggtgtgcaaatccatgcaaaactgaccggtgtgcaaatccatgcaaaactga 
 tcgatcagttttgcatggatttgcacaccggtcagttttgcatggatttgcacaccggtcagttttgcatggatttgcaca 
hsa-miR-148a-3p     ggcctcagtgcactacagaactttgtccggtcagtgcactacagaactttgtccggtcagtgcactacagaactttgt 
 tcgaacaaagttctgtagtgcactgaccggacaaagttctgtagtgcactgaccggacaaagttctgtagtgcactga 
U3 1 3 copies ggccaagtttctctgaacgtgtagccggaagtttctctgaacgtgtagccggaagtttctctgaacgtgtag 
 tcgactacacgttcagagaaacttccggctacacgttcagagaaacttccggctacacgttcagagaaactt 
U3 2 3 copies ggccaccacgaggaagagaggtagccggaccacgaggaagagaggtagccggaccacgaggaagagaggtag 
 tcgactacctctcttcctcgtggtccggctacctctcttcctcgtggtccggctacctctcttcctcgtggt 
U3 3 3 copies ggccggagagaacgcggtctgagtccggggagagaacgcggtctgagtccggggagagaacgcggtctgagt 
 tcgaactcagaccgcgttctctccccggactcagaccgcgttctctccccggactcagaccgcgttctctccccgg 
ACA45 3 copies ggccaaaggtagatagaacaggtcccggaaaggtagatagaacaggtcccggaaaggtagatagaacaggtc 
 tcgagacctgttctatctacctttccgggacctgttctatctacctttccgggacctgttctatctaccttt 
U44 3 copies ggcccctggatgatgataagcaaaccggcctggatgatgataagcaaaccggcctggatgatgataagcaaa 
 tcgatttgcttatcatcatccaggccggtttgcttatcatcatccaggccggtttgcttatcatcatccagg 
U78 3 copies ggccatgtagacaaaggtaacactccggatgtagacaaaggtaacactccggatgtagacaaaggtaacactaaaggtaacact 
 tcgaagtgttacctttgtctacatccggagtgttacctttgtctacatccggagtgttacctttgtctacat 
Supplementary Table 4 Oligos used to insert into dual fluorescence reporter. 
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